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ABSTRACT 
CHARACTERIZATION OF A MULTIPLE ANTIBIOTIC RESISTANT FACTOR 
FROM PROTEUS MIRABILIS 
A Proteus mirabilis isolate associated with nosocomial urinary 
tract infection was obtained from the clinical microbiology labora-
tory at Hines Veterans Administration Hospital. The isolate, strain 
2138, was resistant to at least ampicillin (Ap), carbenicillin (Cb), 
gentamicin (Gm), tobramycin (Tm), kanamycin (Km), neomycin (Nm), 
streptomycin (Sm), colistin (Cs), cephalothin (Cl) and tetracycline 
(Tc). Neutral sucrose gradient sedimentation of plasmid DNA isolated 
from strain 2138 revealed the presence of three size classes of 
plasmids, designated pFLlOOlO, pFL10020, and pFL10030. The molecular 
weights of the plasmids, calculated from contour length measurements 
of electronmicrographs, were 90 X 106 , 5 X 106 , and 27 X 106 re-
spectively. A resistance phenotype of Ap, Cb, Gm, Tm, Km, Sm and Cl 
was transferred to Escherichia coli J53-l via conjugation with strain 
2138. A single plasmid species having a molecular weight of 90 X 106 
was isolated from the transconjugate J53-l (pFLlOOlO). Isolated 
plasmid species from strain 2138 were used to transform ~· coli Cl200-l 
to antibiotic resistance. No detectable transfer of antibiotic re-
sistance occurred with the pFL10030 DNA, and only Ap and Cb resistance 
was transferred using pFL10020 DNA. Successful transfer of the 
resistance phenotype of Ap, Cb, Gm, Tm, Km, Sm, and Cl to strain 
iv 
Cl200-l was achieved using pFLlOOlO DNA. Agarose gel electro-
phoresis of partially purified plasmid DNA from strain 2138 and the 
transformant Cl200-l (pFLlOOlO) showed a single plasmid species in 
the transformant that co-migrated with pFLlOOlO from strain 2138. 
The host range of the pFLlOOlO plasmid was investigated. The plasmid 
was transferred by conjugation to several genera of the Entero-
bacteriaceae and to the non-Enterobacteriaceae species, Pseudomonas 
aeruginosa. However, the plasmid did not transfer to the unrelated 
species Agrobacterium tumefaciens, or to some of the Enterobacteriaceae 
species tested. 
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CHAPTER I 
INTRODUCTION 
A. REVIEW OF RELATED LITERATURE 
1. Historical Perspective 
The discovery of the 'IDiracle drug" (27) penicillin in 1941, and 
subsequent antibiotics in the last forty years has revolutionized 
medicine by drastically reducing morbidity and mortality from microbial 
disease (21). Unfortunately, the versatility of microorganisms in 
their adaptive capabilities has presented a formidible array of de-
fenses against antibiotics. The acquisition of multiple antibiotic 
resistance by the Enterobacteriaceae and related gram-negative 
organisms has become a significant problem in modern medicine. 
Knowledge of drug resistant microorganisms is as old as chemo-
therapy itself. In 1907, Paul Ehrlich (21) gave the first detailed 
report of Trypanosome brucei which became resistant to the trypano-
cidal activity of paraosaniline (arsenic) after repeated exposure to 
the drug. Subsequently, with the introduction of each anti-microbial 
agent came evidence of microbial resistance to its inhibitory 
actions. 
Attempts to explain this phenomenon led to two prevalent 
theories. One view held that the resistant cells developed by 
spontaneous mutation independant of drugs and were selected by their 
use. The opposing view held that the resistant cells were the adap-
tive product of interaction between the drug and bacterial cell. 
1 
2 
In 1943, Luria and Delbruck (64) established the fluctuation 
analysis which provided a statistical method to determine the prob-
ability distribution of the number of resistant bacteria to be ex-
pected on the hypothesis of mutation. Application of this method to 
penicillin resistance in Staphylococcus by Demerec (20) indicated that 
the resistance arose by spontaneous mutation where the drug acted as a 
selective agent. Further use of replica plating proved that drug 
resistant mutants appeared spontaneously before exposure to the drug, 
thus confirming the hypothesis of spontaneous mutation. 
Outbreaks of Shigellosis in post war Japan challenged this theory. 
Initially, Shigella dysenteriae responded to sulfanalamide treatment, 
but the effectiveness of the drug waned after five years with the 
emergence of sulfanalamide resistant Shigella strains. The intro-
duction of newer antibiotics including streptomycin, tetracycline and 
chloramphenicol, initially circumvented the problem. However, within 
seven years, clinical isolates were found to be resistant to each 
antibiotic, and some multiply resistant to all of the antibiotics used 
(110). Since the frequency of spontaneous mutation to resistance to 
one drug is small, 10-7 to 10-8 (21), and independent of that to 
another antibiotic, the frequency of spontaneous mutation to resis-
tance to all four antibiotics simultaneously would be less than l0-28 
(71). Given this probability, the occurrence of multiply resistant 
Shigella dysenteriae and Escherichia coli from the same patient led 
the Japanese microbiologists to the conclusion that sets of resistant 
genes were conferring resistance to several antibiotics simultaneously 
and were being transferred en bloc between bacteria of the same and 
different species (106). 
Genetic exchange among bacteria had been previously demonstrated 
(75). It had been established that bacteria could transfer genetic 
information by transformation (60) in which the deoxyribonucleic acid 
(DNA) extracted from cells of one strain could induce heritable 
changes in cells of another, transduction (78) in which bacterial DNA 
is carried by a phage vector to another cell, and conjugation (61) 
in which genetic material is transferred through direct cell to cell 
contact. 
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In 1959, Akiba and co-workers (1) and Ochiai and co-workers (85), 
independently demonstrated the transfer of multiple resistance traits 
from Escherichia coli to Shigella dysenteriae. In 1960, Mitsuhashi and 
associates (74) demonstrated that the drug resistance was not mediated 
by filterable agents, was independant of chromosomal transmission, and 
could be spontaneously lost. Watanabe and Fukasawa (112) confirmed 
that the transfer of drug resistance was mediated by cell to cell con-
tact by use of the interrupted mating technique. These workers hypoth-
esized that the resistance factors were carried on an episome termed 
the resistance transfer factor (RTF) having autonomous replication and 
being separate from F factors. The term R factor was proposed by 
Mitsuhashi in 1960 and was adopted to describe the postulated episomes. 
Recently, the suggestion was made to supplant this term with the more 
acceptable designation, R plasmid (83). 
Simultaneous to the Japanese study came worldwide reports of R 
plasmids isolated in several gram-negative species resistant to 
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sulfanalamide, streptomycin, tetracycline and chloramphenicol and 
other antibiotics in an array of combinations. Occurrence of multiply 
resistant clinical isolates has increased steadily to become a major 
medical concern (74). These vast numbers of R plasmids have been 
given various designations. The term R plasmid is currently accepted 
to designate a plasmid that carries genetic information for resistance 
to antibiotics and/or other antibacterial drugs. A resistant donor is 
a bacterial strain that is capable of stably transferring resistant 
genes, usually by conjugation, to a recipient strain and is referred to 
as the R donor (83). 
2. Physical Characterization of Plasmids 
a. Chemical Composition 
Plasmid molecules have been isolated and shown to consist of 
double stranded deoxyribonucleic acid (DNA)(23). Visualization with 
the electron microscope (111) has revealed that plasmids exist as co-
valently closed circular (CCC) DNA molecules (111). The molecular mass 
of plasmids may vary from less than 106 to greater than 108 daltons, 
with an average size of 6 x 106 daltons. R plasmids may carry as many 
as 100 genes, including traits other than drug resistance (8). 
The inherent bouyant density of plasmid DNA, or mean base com-
position, is a consistent characteristic of a plasmid and can be used 
to separate plasmids of differing densities from each other (19, 66). 
A more specific measure of the evolutionary relatedness of plasmids 
can be determined by DNA-DNA hybridizations and heteroduplex analysis 
(47, 13). The latter method has been useful for mapping insertions, 
deletions and duplications in plasmid DNA molecules (44). 5 
b. Dissociation and Reassociation of Composite R Plasmids 
Many R plasmids are composite structures consisting of resis-
tance transfer factor (RTF) and resistance determinants (r-deter-
minants) components, each of which may be capable of autonomous re-
plication under certain growth conditions, 
Anderson and Lewis (3) were the first to observe that R plas-
mids may exist as multiple replicons which can dissociate and re-
associate depending upon host species and culture conditions. In 
their system, the transfer factor, designated Delta, was found to 
transfer independently of the resistance traits. When Delta was 
transferred into a cell having resistance traits to sulfonamides and 
streptomycin, but lacking transfer capability, the plasmids reformed 
and transferred both Delta and the resistance traits to a recipient. 
This provided the basis for the resistance mobilization test Anderson 
developed to detect the presence of transfer factors in other wild type 
strains (2). 
Anderson (2) classified plasmids into two groups: Class 1 and 
Class 2, which were also designated by Clowes (73) as plasmid co-
integrate and plasmid aggregate, respectively. In Class 1 plasmids, 
the resistance determinants and the transfer factor farm a covalently 
bonded complex which is maintained and transferred as a single linkage 
group. In Class 2 plasmids the resistance determinants and the 
transfer factor exist as discrete plasmids, but are transferred to-
gether by an unknown mechanism, probably other than covalent linkage. 
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Guerry et al. (34) demonstrated that some plasmids were capable of both 
Class 1 and Class 2 transfers and that the host plays a significant 
role in plasmid organization. 
The Anderson model proved inadequate in explaining the mole-
cular nature of dissociated plasmids found in other species of Entero-
bacteriaceae, and there remains a controversy surrounding the proposed 
models for dissociation. The plasmid R-NRl (also designated R~22and 
R-100) confers resistance to sulfonamides, streptomycin, ampicillin and 
tetracycline. Analysis has shown the plasmid isolated from !· coli 
to have a molecular mass of 60 x 106 daltons and a bouyant density of 
1.711 g/cc. However, when isolated from Proteus mirabilis this is not 
the case. 
In the P. miribilis host, multiple R plasmid DNA bands were 
observed in cesium chloride density gradients when host cells were 
cultured in drug-containing media (73). Rownd (93) has shown that the 
molecular mass, density and copy number of plasmids depend upon the 
conditions under which the Proteus cells are cultured. When cultured 
in a drug-free medium, R-NRl DNA propagated in Proteus forms a single 
satellite band with a density of 1.712 g/cc and a mass of 63 x 106 
daltons. After prolonged growth of cells in medium containing any of 
the drugs to which R-NRl conferrs resistance, except tetracycline, a 
band of greater density, 1.718 g/cc, is observed. If the plasmid DNA 
is isolated during transition between these two density states, a 
complex of molecules having a broad spectrum of densities between 
1.712 and 1.718 g/cc was observed. 
Proteus mirabilis containing a segregant of R-NRl was found to 
be resistant to tetracycline but not to any other drugs. Since the 
trait was transmissible it was thought to contain the transfer factor 
linked to the tetracycline gene and was designated RTF-Tc (95). When 
grown in medium containing tetracycline this strain revealed a single 
satellite in cesium chloride gradients having an intrinsic bouyant 
density of 1.710 g/cc and mass of 49 x 106 daltons (SO). Isolation of 
the segregant from cultures in back transition, i.e., shift from anti-
biotic medium to antibiotic-free medium, showed two peaks in cesium 
chloride gradients corresponding to densities of 1.710 and 1.718 g/cc. 
Table I summarizes the data. 
Rownd (92) proposed the following model to explain the phe-
nomenon. The R-NRl plasmid consists of two component parts: the 
transfer factor linked to the tetracycline determinant (RTF-Tc) and 
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the r-determinants. In drug-free medium, R-NRl exists as a single 
species having a molecular mass of 63 x 106 daltons. In drug-containing 
medium, there is a selection for cells having a higher level of drug 
resistance as these would grow faster. The r-determinants are ampli-
fied by the dissociation of the composite R plasmid into individual 
replicons. The amplified r-determinants exist as poly-r-determinants 
joined in tandem repeats (89), which combine with a single RTF-Tc to 
form poly-r-determinant R plasmids. The broad intermediate density 
band found in back transition is indicative of varying copies of r-
determinants per molecule. The small plasmid (14 x 106 daltons) seen 
in back transition represents a single r-determinant as would be 
Tab1e 1. 
Molecular properties of plasmid R-NRl from cells cultured in different media.a 
Plasmid 
NRl 
NRl 
NRl 
RTF-Tc 
Culture 
Conditions 
antibiotic 
free 
antibiotic 
back 
. i b trans1t on 
antibiotic 
free 
CsCl Gradients 
Satellite Bands 
1 
1 
2 
1 
a Data from Hashimoto and Rownd (36). 
Bouyant Density 
(g/cc) 
1. 712 
1. 718 
1. 710 
1. 718 
1. 710 
Countour Length 
(].lm) 
37.0 
8.2 - 42.0 
28.7 
8.3 
28.7 
Molecular Mass 
(daltons) 
63 X 106 
14-87 X 10 6 
6 49 X 106 14 X 10 
49 X 106 
b Cells originally grown in antibiotic containing medium then placed in antibiotic-free medium. 
00 
9 
predicted from differences between the composite R-NRl and the RTF-Tc 
molecular masses. 
Falkow (23) contends that the large poly-r-determinants exist 
separately more often than in tandem with the RTF-Tc and account for 
the 1.718 g/cc peak in cesium chloride gradients and that during 
stationary phase in Proteus, R-NRl exists as a dissociated molecule. 
Cohen and Miller (12) support this view. However, all investigators 
unanimously agree that R-NRl can dissociate in Proteus hosts into 
separate units of replication, that the smaller units contain most of 
the drug resistance genes present in multiple copies, and that the 
RTF linked to the Tc resistance gene is present in only a few copies. 
The transition of R-NRl has not been observed in E. coli 
harboring the plasmid which is resistant to very high concentrations 
of drugs. However, an increased number of copies of monomeric com-
posite R-NRl plasmids per cell were found (95). Transition of R 
plasmids does not occur with most species and seems to be a peculiar-
ity of the host species which harbors the plasmid (34). The behavior 
of R-NRl in P. mirabilis is typical of several other R plasmids found 
in this species. 
c. Plasmid Copy Number 
The number of copies of a plasmid per cell (copy number) is 
usually estimated by comparing the ratio of plasmid DNA to chromosomal 
DNA with the ratio of their respective sizes (molecular masses) (94). 
There is usually a constant ratio of plasmid DNA to chromosomal DNA 
throughout the exponential phase of growth which indicates that there 
10 
is a fixed number of rounds of plasmid replication each division cycle 
(50). rhe number of rounds of plasmid replication is a characteristic 
of each type of plasmid and is one of the features of the control of 
its replication. In order for a plasmid to be maintained stably in a 
population of cells, there must be at least one round of plasmid 
replication during each division cycle. Many plasmids are under 
stringent control, that is, only one to two copies exist per chromo-
some; others are under relaxed control having several copies per 
chromosome. 
By selecting for increased levels of drug resistance, it has 
been possible to isolate R plasmid mutants which have an increased 
number of copies per cell. These mutants have been referred to as 
round of replication (ROR) mutants, since they undergo an increased 
number of rounds of replication during the bacterial division cycle 
(55). These ROR mutants have the same size as the wild type R plasmids, 
showing that the number of copies of the drug resistance genes has not 
been increased by the formation of multimeric structures, as in transi-
tion in~· miribilis (SO). 
d. Insertion Sequences 
Insertion sequences (IS) are specific nucleotide sequences, of 
800 base pairs or more, which have the ability to insert or excise 
from a segment of DNA. Initially discovered as "hotspots" for recom-
bination (55), they provide a recognition site or area of homology 
between two genetic elements allowing for interaction. These se-
quences (IS-1, IS-2, IS-3, etc.) have been located at the interfaces 
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between the RTF and r-determinants of· R-NRl and several composite R 
plasmids (44). This suggests that recombination between IS elements 
may provide the mechanism by which an R plasmid can dissociate into 
its individual replicons (90). 
e. Transposition 
Mobility has been associated with several drug resistance 
markers. Foster and co-workers (28) attempted to introduce two in-
compatible plasmids, one conferring resistance to chloramphenicol but 
not to tetracycline and the other with opposite traits, into a single 
bacterium by selecting for transconjugates resistant to both anti-
biotics. The stable derivatives that were isolated were found to 
carry the tetracycline marker on the bacterial chromosome. The unit 
carrying the resistance marker was flanked by two inverted IS-3 
elements (28). The tetracycline marker comprised a mobile determinant 
displaying the capacity for insertion and excision which was formerly 
thought to be a property of the insertion sequences themselves (40). 
This capacity has been described as translocation or transposition, 
and the unit that is transferred has been termed a translocon or 
transposon. The tetracycline transposon has been designated Tn9 
(formerly TnD). Transposition has been shown to be independant of 
the cellular recombination (rec) systems (5, 57, 100). 
Subsequently, several transposons have been identified (90). A 
penicillinase producing transposon, Tnl, has been found in several R 
plasmids. Heteroduplex mapping has shown Tnl to be flanked by in-
verted repeats of less than 100 base pairs (40). A transposon, Tn9, 
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coding for chloramphenicol deactivation has been isolated in which no 
inverted repeats were detected. It has been suggested that trans-
position may not necessarily involve IS elements (83). 
It is not known if there is a common mechanism or a variety of 
mechanisms for transposition of Tn and IS elements. The functional 
significance of the inverted repeats has not been elucidated, although 
it has been suggested that they are a stabilizing factor (63). 
Evidence does imply that insertion is not random. However, selec-
tivity may be low, and excision has been known to cause deletions (41). 
Mutagenesis of bacterial and plasmid genes by insertions of trans-
posons has also been demonstrated (90). The role of these genetic 
elements in the evolution and reassortment of R plasmids is thought to 
be significant (55). The use of antibiotics may create selective 
pressures that encourage the transposition of Tn-like elements onto 
transfer factors, allowing for construction and evolution of the com-
posite R plasmid. A plasmid may acquire several r-determinants in this 
manner becoming a multiply resistant plasmid. 
3. Genetic Characterization of Plasmids 
a. Replication 
The most important property of an R plasmid is its ability 
to replicate autonomously in the cytoplasm of the host cells. The 
autonomy of the plasmid has been demonstrated by isolation of dis-
crete plasmid molecules. Inhibition of plasmid replication achieved 
by use of acridine dyes which do not affect cell growth provides 
convincing evidence of the independance of plasmid replicons (113). 
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Although plasmid replication is physically separate from the host 
chromosome, the limited number of plasmid molecules per host chromo-
some (109) and the unique time in the cell cycle of plasmid replication 
(117) suggest that cellular control exists. Rownd (SO) has shown that 
the number of plasmids per chromosome (copy number) varies with host 
bacteria. The plasmid R-NRl in ~· coli exhibits stringent control 
(single copy) while in f· mirabilis relaxed control (multicopy) is 
observed (79). Chromosomal mutations making plasmid replication 
temperature sensitive have been characterized and support the view 
that there exist cellular controls on independent plasmid replicons 
(114). 
Studies on plasmid replication indicate that one or more proteins 
are required for the initiation of R plasmid replication, and that a 
small pool of "initiator protein" is present in the cells during ex-
ponential growth. Some plasmids require ribonucleic acid (RNA) 
synthesis for replication while others, including R-NRl, do not (95). 
b. Incompatibility 
The introduction of a second plasmid into a plasmid bearing 
host may lead to the elimination of one plasmid, or segregation of 
the plasmids in subsequent generations (19). This phenomenon of 
mutual exclusion is shown by most known plasmids regardless of copy 
number and is a manifestation of relatedness of plasmids. This 
situation has permitted the assignment of plasmids to incompatibility 
sets, of which there are at least 26 among the enteric bacteria and 11 
among those of Staphylococcus aureus (84). 
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Early models for incompatibility postulated that there is a 
specific membrane attachment site essential for plasmid replication, 
simular to that of the chromosome (14), and that competition for that 
attachment site may be coupled with production of a specific inhibitor 
of replication (43). Novick and Hoppensteadt (84) consider incom-
patibility to be a complex phenomenon involving several different 
plasmid genetic systems that either influence or determine autonomous 
incompatibility and its specificity. These determinants include the 
replication origin, the mechanism controlling copy number and the 
putative recognition system for partition (which may be considered 
as a centromere analog). There may be others, as yet unidentified. 
According to Datta (16) plasmids are said to be incompatible 
if a host cell harboring a plasmid is immune to infection with a 
second plasmid. Compatibility between the two is indicated by 
retention by the host of both-incoming and resident plasmids. In-
compatibility is a transitive phenomenon i.e., if A is incompatible 
with B, and B with C, then A is incompatible with C. However, 
compatibility is not a transitive phenomenon (84). The system of 
classification into incompatibility groups has become inadequate due 
to difficulties in establishing experimental standard recipients, lack 
of distinguishable genetic markers on some plasmids and plasmid-
plasmid interactions (31). 
Interestingly, a correlation has been demonstrated between in-
compatibility grouping and DNA relatedness. Plasmids within an in-
compatibility group almost always show extensive DNA homology, whereas 
plasmids of different groups rarely show significant homology (24). 
Although exceptions exist (24), extensive homology exists between 
plasmids of incompatibility group W (98) and within other groups. 
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All the plasmids of this group determine different resistant patterns, 
were detected in different bacterial genera and were isolated in 
different parts of the world. The DNA of each hybridized with that 
of the others to at least 75% of its total length. Electron micro-
scopy of heteroduplex molecules of these plasmids and their re-
combinants and deletion mutants, have permitted the identification 
of the DNA loci encoding the various resistance genes (98). 
c. Chromosomal Integration 
Although plasmids exist as extrachromosomal elements inde-
pendant of the host chromosome, some, termed episomes, have the ability 
to integrate into the chromosome (74). This ability is host specific. 
For example, some plasmids behave as episomes in!· coli, but not in 
P. mirabilis (80). Some plasmids, once integrated, are able to excise 
from the chromosome. Abnormal excision may explain the presence in 
plasmids of genes governing host cell functions such as lac genes 
found in a Proteus plasmid (103). 
d. Plasmid-Plasmid Interactions 
Crossing over and recombination occur between different plas-
mids allowing genetic exchanges and plasmid-plasmid interaction. Re-
combinant plasmids have also been created in vitro by use of re-
striction endonucleases (105). These can be reintroduced into the host 
bacteria by the transformation process. Although it is presumed that 
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replication and integration of plasmids is similar to models for the 
chromosome, the molecular mechanism has not been fully elucidated. 
e. Transmissibility 
The ability of R plasmids to spread throughout a bacterial 
population is a major medical problem. Conjugal transmissibility 
occurs in three steps (76). First, the production of the pilus 
(conjugal bridge) is thought to provide the attachment site between 
donor and recipient cell. Following the formation of the initial 
specific contacts, many donor and recipient cells form wall to wall 
contacts (76). Second, the formation of specific contacts is thought 
to trigger a set of metabolic events that lead to the exit of DNA 
from the donor. These events prepare the DNA for exit and are termed 
mobilization. There has been question as to the function of the pilus. 
Some workers believe it to be merely a means of bringing the cells 
into contact and not used for passage of DNA (111). Others believe 
that the DNA passes through the pilus to the recipient cell. Re-
gardless, the DNA is transferred as a single linear strand which must 
replicate and circularize in the recipient cell. Lastly, the genetic 
expression of the R plasmid phenotype in the recipient must occur. 
Interestingly, bacteriophages have been isolated which adsorb only 
to certain conjugation pili (68). 
In addition to transmissible R plasmids, a large number of R 
plasmids have been isolated in the Enterobacteriaceae and S. aureus 
which cannot mediate their own transfer from cell to cell. These non-
transmissible R plasmids usually confer resistance to one or two drugs, 
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are present in multiple copies per cell, and have molecular masses of 
only 5-10 megadaltons (95). Several bacterial genera also harbor 
transfer factors (sex factors) which do not carry drug resistance gene. 
Nontransmissible R plasmids can be mobilized (transferred to a re-
cipient cell) by sex factors, transfer factors, or by transmissible R 
plasmids when both are present in thesamehost cell (2). The mechanism 
of transfer appears to involve covalent linkage between the non-
transmissible plasmid and the transfer factor. Transfer factors and 
small nontransmissible R plasmids can co-exist within the same host 
and not recombine, as is true for any two compatible plasmids (95). 
f. Host Range 
Certain plasmids have the ability to infect a variety of un-
related bacterial strains, other plasmids are limited to a single host 
strain or related host species. The R plasmids found among the Entero-
bacteriaceae and related gram-negative species generally are trans-
ferrable within the group. The frequencies of R plasmid transfer differ 
considerably among the species and depend upon the specific donor and 
recipient cells, mating conditions, and origin of the plasmid. Gener-
ally, !· coli, Shigella, Citrobacter and Klebsiella Enterobacter 
species are useful donors and recipients. However, species of Proteus, 
Salmonella and Serratia generally do not transfer plasmids at high 
frequencies in mating experiments (22). 
g. Transduction 
Generalized transduction provides an additional way of trans-
ferring genetic material from one bacterial parent to another. The 
agents active in transduction are phage-like particles that have en-
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capsulated a fragment of bacterial DNA (81, 99). The significance of 
plasmid transduction in nature is uncertain, but it provides a useful 
genetic tool. In some cases all of the resistance traits and trans-
missibility can be transduced by phage, while, in other cases, only 
certain genes are transduced. The size of the DNA molecule that can 
be incorporated into the phage capsule probably determines the number 
of plasmid genes which are transduced. This phenomenon of "trans-
ductional shortening" has been useful in determining the genetic 
sequence of some plasmids (99). 
In the transduction of an R plasmid conferring resistance to 
sulfonamide, streptomycin, tetracycline and chloramphenicol to 
Salmonella typhimurium using phage P-22 as vector, transductants re-
ceived either sulfonamide-streptomycin-chloramphenicol resistance en 
bloc or tetracycline alone. Only in the latter case could the re-
sistance then be transmitted through conjugation (108). In later ex-
periments with the same plasmid the resistant traits were segregated 
in the transductants allowing for the construction of a genetic map 
of the plasmid (110). This indicated that the resistance genes are 
indeed different and that multiple drug resistance is not some plea-
trophic effect of a single gene. The most important conclusion is that 
the genes determining resistance and those determining conjugal ability 
are distinctly separable. 
4. Molecular Basis of Drug Resistance 
Bacterial resistance to a particular antibiotic or related series 
of antibiotics depends on a single mechanism, although occasionally a 
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combination of mechanisms may be found in the same organism (78). The 
most frequently found mechanism of resistance will be discussed here. 
a. Beta-Lactam Resistance 
The most prevalent mechanism of resistance is conversion of 
an active drug to an inert product by an enzyme found only in resis-
tant bacteria. The existence of genes coding for drug inactivating 
enzymes in R plasmids of Enterobacteriaceae was first demonstrated 
for enzymes hydrolyzing the beta-lactam drugs (17). A single pre-
dominant plasmid-associated beta-lactamase was found in gra~negative 
R plasmids of wide taxonomic and geographical range, and was termed 
"TEM-like" beta-lactamase (54). 
In terms of physical properties, substrate specificity and 
specific activity, most beta-lactamases fall into two general types: 
the TEM type (also called type 1) and the 0 type (also called type 2). 
The former type has a broader general activity on penicillins and 
cephalosporins, but considerably less on oxacillin. The latter has 
the opposite effect (39). The TEM type may be coded for by chromosomal 
or plasmid genes and is associated with transposons. The 0 type has 
only been found associated with plasmids (22). 
These beta-lactamases are capable of hydrolyzing the beta-lactam 
ring of antibiotics rendering them inactive. In the gram positive 
bacteria the synthesis of beta-lactamase is induced by the presence 
of the antibiotic and the enzyme is excreted, inactivating its sub-
strate extracellularly (17). Conversely, gram-negative cells synthe-
size the enzymes constitutively, but in smaller quantities than gram-
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positive cells, and the enzyme remains periplasmic (17). 
A second, less common family of penicillin-inactivation enzymes 
has been characterized. The enzyme, an amidase, inactivates the drug 
by hydrolyzing the CO-NH bond between the side chain and the 6-amino 
group in the penicillin acid residue (22). Enteric bacteria have 
been found to elaborate this enzyme, but R plasmid mediated resistance 
to penicillin has been solely associated with beta-lactamase activity 
(54). 
b. Chloramphenicol Inactivation 
The mechanism of R plasmid mediated chloramphenicol resistance 
involves a drug-inactivation enzyme that catalyzes acetylation of 
chloramphenicol in the presence of acetyl-coenzyme A. The vast 
majority of R plasmid-containing clinical isolates that are chloram-
phenicol resistant have been found to elaborate this constitutive 
enzyme, chloramphenicol acetyl transferase (45). Thus far the enzyme 
has appeared to be reasonably homogeneous in all isolates examined 
regardless of their bacterial host and geographical location (22). 
However, there are significant differences in enzyme levels observed 
among different R plasmid-containing chloramphenicol resistant isolates 
when the same R plasmid is transferred from host to host. As pre-
viously mentioned, transpositional activity has been associated with 
chloramphenicol resistance (28). This could well explain the observed 
homogeneity of chloramphenicol acetyltransferase activity found in the 
various unrelated species. 
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c. Aminoglycoside Resistance 
The aminoglycosides constitute a large, diverse, but 
structurally related family of antibiotics. Gentamicin, tobramycin, 
streptomycin, kanamycin and other aminoglycoside antibiotics are still 
commonly employed against gram-negative infections. The mechanism of 
chromosomal resistance to streptomycin is associated with specific 
alterations of the target site of the antibiotic on the 30S ribo-
somal component. Such alterations prevent binding of the antibiotic 
(77). However, this type of resistance is rare among clinical iso-
lates (22). 
Studies on the biochemical mechanisms of R plasmid-mediated 
aminoglycoside resistance indicate that they are not associated with 
ribosomal alteration, but rather with a remarkable number of enzymes 
which modify the antibiotics (107). Despite the variety of enzymes, 
there are only three known classes of inactivating reactions. The 
antibiotics are inactivated by either N-acetylation, phosphorylation 
or adenylylation of susceptible amino or hydroxyl groups, using 
adenosine triphosphate (ATP) or acetyl coenzyme A as cofactors (18). 
Most aminoglycoside antibiotics are subject to more than one inactiva-
tion reaction. The enzymes are constitutively synthesized and are 
retained within the bacterial cell (18). 
Those enzymes involving phosphorylation of antibiotics are 
termed the aminoglycoside antibiotic phosphotransferase enzymes. 
Based on their physical properties and substrate specificity there 
are three groups of enzymes in this class. The first group called 
the kanamycin phosphotransferases has three types: 1) the first 
inactivates kanamycin (Km), neomycin (Nm), ribostamycin (Rb), 
paromycin (Pm), and lividomycin (Lv); 2) the second inactivates 
Km, Nm, Rb, Pm and butarosin (Bt); 3) and the third inactivates 
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Km, Rb, Bt and Lv. The second group contains only a single activity 
ribostamycin phosphotransferase, which inhibits Rb action exclusively. 
The third group contains two streptomycin (Sm) inactivating enzymes: 
Sm-3'-phosphotransferase and Sm-6'-phosphotransferase (78). 
Acetylation of aminoglycoside antibiotics is carried out by 
the aminoglycoside antibiotic acetyltransferase enzymes. There are 
three major groups of enzymes in this category. The first is the 
Km-6'-N-acetyltransferase group of which four major types are known: 
1) the first inactivates Km and Nm; 2) the second inactivates Km, 
Nm and gentamicin (Gm); 3) the third inactivates Km, Gm and 
3'-4'-dideoxy kanamycin (Km-D); and 4) the fourth inactivates Km, Gm, 
Km-D and amikacin (Ak). The second group includes the aminoglycoside 
3'-acetyltransferase I enzyme which inactivates Gm and sisomycin (Ss), 
and aminoglycoside 3'-acetyltransferase II which inactivates Gm, Ss, 
Km and tobramycin (Tm). The third group of acetylating enzymes 
contains aminoglycoside 2'-acetyltransferase which inhibits the action 
of Gm, Nm, Km, Km-D, Rb, Lv and Bt (78). 
There are four groups of enzymes known that effect the adenyly-
lation of aminoglycoside antibiotics. These are called the amino-
glycoside antibiotic adenylyltransferase enzymes. They are 1) Sm-
adenylyltransferase which inactivates Sm and spectinomycin (Sp); 
2) Sm-6'-adenylyltransferase which inactivates Gm, Km, Km-D and Tm; 
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3) Gm-Km-2'-adenlylytransferase which inactivates Gm, Km, Km-D and Tm; 
and 4) Tm-4'-adenylyltransferase which inactivates Tm, Km, Nm, Bt, Pm, 
and Ak (78). 
d. Non-Enzymatic Resistance Mechanisms 
Tetracycline resistance is probably the most common R plasmid-
mediated drug resistance found in nature (21). Although the specific 
mechanism whereby tetracycline is inhibited is not known, the drug is 
probably blocked from entering the cell in sufficient concentrations to 
inhibit ribosomal function. The resistance determinant may code for a 
new membrane protein which will not bind tetracycline. Franklin and 
Cook (29) have shown that the decreased uptake of the drug, and con-
comitantly the level of resistance, is appreciably increased in the 
presence of tetracycline, suggesting that the inhibitor of tetracycline 
is inducible. There is no evidence for enzymatic inactivation or 
modification of tetracycline, the resistance appears to be associated 
with modification of cellular permeability of the drug. 
Bacterial resistance to p-aminobenzenesulfonamide (sulfonylamide: 
Sa) and its resistance has been described. Observations that the drug 
is neither destroyed nor modified by R plasmid-containing strains 
suggest that resistance is due to decreased permeability of the cell 
membrane to sulfonylamide (107). Pato and Brown (88) have reported a 
second type of resistance mechanism involving the sulfonylamide sensi-
tivity of the enzyme dihydropteroate synthetase, which decreases in 
accordance with an increase in Sa resistance. Recent findings indi-
cate that the most general mechanism of high Sa resistance in gram-
negative bacteria carrying R plasmids is due to the production of Sa-
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resistant dihydropteroate synthetase which differs from Sa-sensitive 
enzyme produced by sensitive strains in Sa-susceptibility and in various 
enzymological properties (78). 
Bacterial drug resistance may be affected by changes in the 
target site of the drug as mentioned for streptomycin resistance (45, 
77). Streptomycin resistance is caused by mutation of the S-12 pro-
tein of the ribosome which is the ultimate binding site for the anti-
biotic. It is uncertain whether the mutation is induced by the 
presence of the antibiotic. It may result from use of an alternate 
pathway selected after elimination of the primary pathway by strepto-
mycin. Of clinical significance are two forms of antibiotic resistant 
enzymes, a naladixic acid resistant DNA gyrase and a rifampicin re-
sistant RNA polymerase, both of which are examples of alterations of 
target sites of antibiotics (45). 
5. Versatility of Plasmids 
R plasmids are known which also mediate resistance to a number of 
heavy metals, and ultraviolet irradiation. Mercury resistance appears 
to be inducible and associated with enzymatic catalysis (104). The 
mechanism for resistance to other heavy metallic ions, such as nickle 
or cobalt, has not yet been elucidated (22). 
Other plasmids are known which contain genetic determinants 
unrelated to those for antibiotic resistance. Col plasmids have been 
discovered which confer colicinogency to Escherichia coli (42). 
Degradative plasmids found in some species of Pseudomonas have been 
characterized by their ability to code for enzymes that catabolize a 
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great variety of unusual organic compounds by special metabolic path-
ways (42). Plasmids have been described which contribute to the 
virulence of ~· coli by coding for production of alphahemolysins (Hly 
plasmids) (100), enterotoxins (Ent plasmids) and surface antigens 
(101). Many gram-negative species harbor plasmids which do not carry 
genes which can be phenotypically detected. These cryptic plasmids can 
only be detected through DNA isolation techniques (33). 
6. Gram-Positive Bacterial Plasmids 
Plasmids have been isolated from species of Staphylococcus aureus 
which produce beta-lactamase and other antibiotic inactivating enzymes 
(82). Although multiple-resistant strains have been isolated, it has 
been found that each resistant determinant is usually located on a 
different plasmid, and that the plasmids, in general, tend to be 
smaller than those found in gram-negative species (45). It was 
originally thought that Staphylococcal plasmids were non-conjugal (22), 
and although conjugation has been demonstrated it is considered a rare 
occurrence (48). The facts indicate that transduction with phage 
lysates is mainly responsible for acquisition of drug resistance and 
for the wide and rapid distribution of multiple resistance among 
Staphylococci (48). The plasmids may exist in high copy number, up to 
25 copies per cell, which accounts for resistance to high levels of 
antibiotics (48). 
Multiple resistance plasmids have been isolated from species of 
Streptococcus faecalis. These have been shown to effect their own 
transfer through the conjugation process. Additionally, intergenic 
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conjugal transmission has been demonstrated between the streptococci 
and Lactobacillus species (49). Conjugation among streptococcal 
species is no longer considered a rare occurrence (49). 
B. INTRODUCTION TO THIS STUDY 
The prolongation of life in persons with severe underlying 
diseases that affect host defenses combined with the increasing use of 
corticosteroids, immunosuppressive agents, cytotoxic drugs and anti-
biotics has resulted in the emergence of a relatively new spectrum of 
infectious diseases. Ubiquitous previously saprophytic commensals, 
rarely causing infection in the normal host, are now recognized with 
increasing frequency in patients with compromised defense mechanism 
(7). Infections with such organisms pose a dilemma not only in 
diagnosis, because of their relative newness, but in therapy due to 
their increased resistance to conventional antibiotic treatment (52). 
The Center for Disease Control reported in 1978 that 3.6% of 
patients hospitalized in the United States acquired nosocomial in-
fections. More than half of those infections either caused or con-
tributed to the death of the patient (HEW Publication (CDC) No. 78-
8257). Of the nosocomial infections that year, nearly half were 
caused by members of the Enterobacteriaceae and related bacterial 
species. These organisms, termed conditional pathogens, are usually 
present in normal flora and spread by human contact (98). 
This study initially began as an investigation into the in-
creasing frequency of nosocomial infections at Hines Veterans Hospital 
at Hines, Illinois (65). Several strains of Proteus mirabilis isolated 
from clinical specimens were found to be clinically resistant to 
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gentamicin and ampicillin which were commonly used in their treatment. 
one isolate, Proteus mirabilis 2138, was chosen as the subject for this 
study because of its resistance to these and several other antibodies. 
This study was undertaken to elucidate the basis of this multiple-
antibiotic resistance, specifically to determine whether R plasmids were 
involved, and if so, whether they were capable of being transferred to 
other gram-negative conditional pathogens. The aims of this research 
are 1) to study the genetic nature of multiple antibiotic resistance 
in Proteus mirabilis 2138; 2) to characterize the molecular nature of 
that genetic determinant; and 3) to determine the transmissibility and 
host range of the antibiotic resistance pattern. 
CHAPTER II 
MATERIALS AND METHODS 
1. Bacterial Strains 
The bacterial strains used in this investigation are listed in 
Table II. Proteus mirabilis 2138 was isolated at Hines Veterans 
Administration Hospital at Hines, Illinois and found to be resistant 
to both gentamicin and ampicillin/carbenicillin in routine laboratory 
screening. With the exception of the Agrobacterium tumefaciens strains 
which were grown at 30 C, all bacteria were grown at 37 C. For the 
purpose of counter selection, spontaneous rifampicin resistant mutants 
of certain bacterial strains were isolated. This was achieved by 
innoculating sensitive cells on nutrient agar plates containing 5 ~g/ml 
rifampicin. Surviving colonies were picked and restreaked onto plates 
containing progressively higher concentrations of the drug (10, 15, 50, 
75, 100 and 200 ~g/ml) until the clones were able to grow well on 
nutrient agar plates containing 200 ~g/ml rifampicin. The resistant 
clones were maintained in this manner. 
2. Chemicals 
All chemicals used were of the highest quality available and not 
further pruified. Radioactive compounds were purchased from New England 
Nuclear. Enzymes and amino acids were purchased from Sigma Chemical 
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Table II~ 
Standard bacterial strains used. 
S . a tra1n 
Escherichia coli 
J53 
J53-l 
Cl200 
Cl200-l 
CSH-K-12 
Proteus mirabilis 
2138 
Pml5 
Agrobacterium 
tumefaciens 
B6-806 
15955 
Enterobacter cloacae 
1 h . . b Re evant c aracterl.stl.cs 
K-12 pro met FA+ 
K-12 pro met F-A.+ Rmr 
C his met F- A.-
Chis met F-A.- Rmr 
Prototroph 
Hospital isolate, prototroph 
Leu- Trp- Thy- Gal- Nia-
ATCC 23355 Prototroph 
Klebsiella pneumonia 
ATCC 27730 Prototroph 
Proteus vulgaris 
ATCC 6380 Prototroph 
Serratia marcescens 
ATCC 8100 Prototroph 
Pseudomonas aeruginosa 
PA038 leu-38 FP2-
Salmonella typhimurium 
TA1637 LT2 his ade 
Shigella flexneri 
SFl 
a K-12, serotype K-12; 
Asp- Asn- Leu- Ile- Val-
Trp- His- Nia-
C, serotype C. 
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Origin 
S. Falkow 
This labora-
tory 
E. W. Six 
This laboratory 
M. Stodolsky 
Hines 
V.A. Hospital 
R. H. Rownd 
This laboratory 
This laboratory 
w. Yo tis 
w. Yo tis 
w. Yo tis 
w. Yo tis 
R. Olsen 
H. w. Taber 
R. J. 
Christiansen 
b Asn - asparagine, Asp - aspartic acid, His - histadine, Ile - isoleu-
cine, Leu - leucine, Met - methionine, Pro - proline, Trp - tryptophan, 
Val - valine, Ade - adenine, Nia - niacin, Thy - thymidine and 
Gal - galactose. 
Company, agarose (HGT) was purchased from SeaKem, Pharmaceutical 
companies provided many of the antibiotics used for this study. 
3. Media 
Complex media used were: nutrient agar (NA), containing per 
liter 8.0 g Nutrient Broth (Difco) and 12.0 g agar (Difco); L Broth, 
containing per liter S.O g yeast extract (Difco), 10.0 g tryptone 
(Difco) and S.O g NaCl; MacConkey's Agar (Difco); and Mueller-Hinton 
Agar (M-H) (Difco), 
Minimal medium for Escherichia coli (&~) contained per liter: 
3.0 g K2HPo4 , 1.0 g KH2Po4 , S.O g NH4Cl, 1.0 g NH4No3 , 2.0 g Naso4 
(anhydrous) and 0.1 g MgS04 ·7H2o (86). 
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Minimal medium for Pseudomonas aeruginosa strains (PM) contained 
per liter: 6.0 g Na2HPo4 , 2.0 g KH2Po4 , 0.1 g MgS0 4·7H20, 1.0 g NaCl 
and S.O g Na3c6HSo7 (sodium citrate) (86). 
Agrobacterium tumefaciens strains were grown in minimal medium 
which contained per liter: 1.0 g Na2HPo4 , 3.0 g KH2Po4 , 0.3 g Mgso4 , 
1.0 g NH4Cl, 0.2 g KCl, 0.2 g CaC12 and 0.1 g Fe2so4 (62). 
Minimal medium phosphate buffers and salts were made separately 
as 20X stock solutions which were autoclaved and added to sterile 
dH2o to achieve lX concentrations. Sterile glucose (SO%) was added 
to achieve a final concentration of 0.2%. To sustain auxotrophic 
strains SO ~g/ml of the appropriate amino acids, 2S ~g/ml nucleoside 
or 10 ~g/ml nicatinamide were added. 
tained 1.2% agar. 
Solidified minimal medium con-
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4. Determination of Minimal Bactericidal Concentrations (MBC) 
The minimal concentration of an antibiotic necessary to kill a 
suspension of cells (MBC) was determined by the tube dilution technique. 
Tubes containing 10 ml of serially diluted antibiotic (10-1 - 108) in L 
broth were innoculated with 1 ml of a bacterial suspension (approxi-
mately 50 Klett units, Klett-Summerson Photoelectric colorimeter model 
800-3, No. 66 red filter) and incubated overnight. A 0.1 ml sample 
from each tube was plated on NA and incubated overnight. The lowest 
dilution of antibiotic that yielded no growth on the NA plate was 
given as the MBC. 
5. Determination of the Antibiotic Resistance Spectrum 
The Kirby-Bauer disk diffusion technique (69) was used to deter-
mine the antibiotic resistance spectrum. Onto Mueller-Hinton plates 
confluently streaked with a bacterial suspension were placed disks 
containing antibiotics. The plates were incubated at 37 C for 24 h. 
Zones of inhibition of bacterial growth around each disk were measured 
and compared to standard charts relating zone diameter to antibiotic 
resistance. Results were recorded as resistant (R) or sensitive (S). 
Donor, recipient, transconjugate and transformant strains were tested 
for resistance to the following drugs: gentamicin (Gm), tobramycin 
(Tm), neomycin (Nm), kanamycin (Km), streptomycin (Sm), tetracycline 
(Tc), ampicillin (Ap), carbenicillin (Cb), cephalothin (Cl), colistin 
(Cs) and rifampicin (Rm). 
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6. Genetic Experiments 
a. Conjugations 
Precultures of donor and recipient cells in 10 ml 1 broth 
were grown overnight in a shaking incubator, diluted 1:10 with fresh 
1 broth and grown to late exponential phase (Klett reading of 50-100). 
Conjugation mixtures consisted of 1.2 ml fresh 1 broth, 0.2 ml donor 
cells and 0.6 ml recipient cells. Controls included 1.8 ml fresh 1 
broth plus 0.2 ml donor cells, and 0.6 m1 recipient cells in 1.4 ml 
fresh 1 broth. The mating mixture and controls were incubated at 
37 C with minimal agitation for 24 h. The titer of imput donor cells 
was determined by plating serial dilutions in triplicate on NA plates. 
The plates were incubated for 24 h and the number of colonies counted. 
The conjugation mixture and controls were centrifuged at 
10,000 rpm for 10 min to pellet the cells which were then washed in 
minimal medium lacking glucose and recentrifuged. The washed cells 
were resuspended in minimal medium, diluted and plated on selective 
media. A 0.1 ml sample of the mating mixture and each control were 
plated in triplicate on selective media. Additionally, the donor, 
recipient and mixed cultures were each plated on minimal medium 
lacking antibiotics, minimal medium containing antibiotics and on 
nutrient agar. The plates were incubated until growth was apparent 
(1-5 days). If no growth appeared after 7 days, negative results 
were recorded. 
Matings that failed to demonstrate detectable transfer of 
antibiotic resistance traits after three trials were repeated using 
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sterile nitrocellulose filter disks to concentrate the cells. Pre-
cultures were grown and diluted and regrown as above, 5 ml aliquots 
of donor and recipient cells were concentrated by vacuum suction onto 
membrane filters (0.45 ~ pore size, Millipore, Inc.) which were 
transferred growth side up to NA plates. Donor and recipient cultures 
were filtered likewise as controls. Following overnight incubation 
the filters were placed in growth flasks containing 10 ml L broth and 
swirled to resuspend the cells. The cell suspensions were pelleted 
by centrifugation, washed twice in minimal medium lacking glucose and 
plated as previously described. 
b. DNA-Mediated Transformations 
The method of Lederberg and Cohen (60) was used to transform 
Escherichia coli strains with purified plasmid DNA. An overnight 
preculture of the recipient strain was used to innoculate 50 ml of 
fresh broth. The cells were grown to exponential phase, transferred 
to a sterile, chilled centrifuge tube and incubated on ice for 5 min. 
The cells were pelleted by centrifugation for 10 min at 10,000 rpm, 
the supernatant was discarded and the cell pellet resuspended in 25 ml 
of ice cold 0.1 ~ MgC12• The cells were transferred to a 30 ml cen-
trifuge tube, iced for 20 min and pelleted by centrifugation as before. 
The cells were resuspended in 2.5 ml of ice cold 0.1 ~ CaC12 and 
transferred to a sterile test tube. 
The transformation mixture contained 0.1 ml purified plasmid 
DNA (50 ~g/ml) in TEN buffer (0.02 M Tris-HCl, 0.001 M EDTA, 0.02 M 
- -
NaCl, pH 8.0) to which 0.2 ml competant cells from above were added. 
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Co~tro~s had additional TEN buffer substituted for the DNA. The mix-
tures were iced for 30 min, 'and then placed directly into a 42 C 
waterbath for 2 min to enable uptake of DNA. To 9.9 ml of pre-
warmed L broth, 0.1 ml of the transformation mixture or control was 
added. These cultures were incubated with shaking at 37 C for 90-120 
min to allow full expression of the antibiotic resistance trait to be 
selected. Appropriate dilutions of the mixtures were plated on 
selective media and incubated until colonies appeared. To check the 
sterility of the DNA and the viability of the cells, 0.1 m1 of each 
was plated onto nutrient agar. 
7. Determination of Plasmid Stability 
To· determine the stability of the plasmids in transconjugate 
strains, 100 clones from each mating were picked onto nutrient agar 
plates. The clones were passed daily onto fresh media. At two week 
intervals, the clones were picked onto two additional sets of plates 
containing either gentamicin (50 ~g/ml) or carbenicillin (100 ~g/ml). 
Those clones that grew on the nutrient agar plates, but failed to 
grow on the gentamicin or carbenicillin plates were retested to 
confirm their loss of resistance. 
8. Radiolabelling of Bacterial DNA 
Overnight precultures of cells grown in minimal medium were used 
to innoculate 30 m1 cultures of minimal medium supplemented with 0.2% 
glucose, 0.5% casamino acids (Difco) and 300 ~g/ml deoxyadenosine to 
enhance the incorporation of (3H)-thymidine (35). At Klett readings 
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of 10, 20, and 30, 0,3 ml of (3H}-th~dine (New England Nuclear Corp,, 
40-60 Ci/mmole, 1 mCi/ml) was added to the culture. The cultures were 
grown to a final Klett reading of 50-100 and the cells harvested by 
centrifugation at 10,000 rpm for 10 min (Sorvall RC-5 centrifuge, 
SS-34 rotor), The cells were resuspended in minimal medium lacking 
glucose, washed and centrifuged as before. The cells were lysed and 
the DNA isolated as described below, 
9. !solation of Extrachromosomal DNA 
Several methods were used to isolate extrachromosomal DNA from 
Proteus mirabilis 2138 and Escherichia £21! JS3-l(pFL10010) strains. 
The methods vary according to-the susceptibility of the bacterial cells 
to lysis and the size of the plasmid molecule being isolated. Cells 
were grown in L broth unless otherwise stated. 
a, Helinski Cleared Lysis 
In a typical preparation (58), a 30 m1 bacterial culture 
grown at 37 C to a cell density registering between 50-100 Klett units 
was harvested by centrifugation, washed twice with cold (4 C) TES 
buffer (0.05 M NaCl, 0.005 M EDTA, 0.05 M Tris-HCl, pH 8.0) and 
pelleted by centrifugation at 4 C for 10 min at 10,000 rpm. The 
pellet was resuspended in 1 m1 cold 25% sucrose in 0.05 ~ Tris-HCl, 
pH 8.0. After the addition of 0.2 m1 of lysozyme (Sigma Chemical Co., 
5 mg/ml in 0.25 M Tris-HCl, pH 8.0) the suspension was placed on ice 
for 5 min. Ethylenediamine-tetraacetic acid (EDTA, 0.4 ml, 0.25 M, 
pH 8.0} was added to the cells followed by 5 min of incubation at 
4 C. Complete cellular lysis was accomplished by the addition of 
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1.6 ~ o~ a detergent mtxture containing 1% Brij 58 and 0.4% sodium 
deoxycholate in 0.0625 M EDTA, 0.05 M Tris~ HCl, pH 8.0. After 5-10 
min at room temperature the suspension became relatively clear and 
viscous and was placed in a 30 ml centrifuge tube and centrifuged for 
25 min at 18.500 rpm (Sorvall RC-5 centrifuge, SS-34 rotor). The 
supernatant containing the plasmid DNA was carefully removed to 
minimize contamination with pelleted chromosomal DNA and subjected to 
cesium chloride-ethidium bromide (CsCl-EtBr) density centrifugation 
as described below. 
b. Guerry Method 
A modification of the Helinski method by Guerry ~ al. (35) 
was used to isolate plasmid DNA for agarose gel electrophoresis. 
Bacterial cells were grown, harvested and treated with lysozyme and 
EDTA as above. Sodium dodecyl sulfate (SDS) was added to a final con-
centration of 1% to achieve complete cellular lysis. After lysis, 4.0 
~ NaCl was added to the viscous solution with gentle mixing to achieve 
a final salt concentration of l M. The lysates were stored at 4 C 
overnight, after which they were centrifuged at 17.000 rpm for 30 min 
at -10 C. The aqueaus phase was removed, doubled in volume by the 
addition of dH2o and prepared for agarose gel electrophoresis as 
described below. 
Plasmid DNA, partially purified by the Guerry method was pre-
pared for agarose gel electrophoresis by the method of Meyers ~ al. 
(71). The supernatant was treated with 20 ~g/ml ribonuclease A 
(bovine pancreas, Sigma Chemical Co., 1 mg/ml in 50 mM sodium acetate 
3S 
pH 5.0, heated at 90 C for 10 min) and incubated for 45 min in a 37 C 
waterbath. After RNase digestion, an equal volume of redistilled 
phenol saturated with 0.05 M Tris-HCl, pH 7.5 was added, phases were 
gently mixed and the emulsion centrifuged at 12,000 rpm for 20 min at 
20 c. The aqueous phase was removed. If it appeared cloudy the phenol 
extraction was repeated. The interphases of all phenol extractions 
were pooled and again extracted with phenol, and the aqueous layers 
combined. An equal volume of chloroform-isoamyl alcohol (24:1 v/v) 
was added, carefully mixed and centrifuged as before to obtain a clear 
aqueous phase. The partially purified plasmid DNA solution was brought 
to a final concentration of 0.3 M sodium acetate by the addition of 
one-tenth volume of 3.0 M sodium acetate solution, and twice the vol-
ume of cold (-20 C) 95% ethanol was added to precipitate the DNA. The 
mixture was well mixed and stored at -20 C overnight. The precipitated 
DNA was pelleted by centrifugation at 12,000 rpm, 20 min, at -10 C. 
The supernatant was decanted and the tube allowed to thoroughly drain. 
The DNA was redissolved in 0.1 ml of buffer containing 0.03 M Tris-
HCl, 0.05 M NaCl, and 0.005 M EDTA, pH 8.0, and analyzed immediately 
by agarose gel electrophoresis or stored at -20 C until ready for use. 
c. Currier Method 
A modification of the Currier method (15) was used to isolate 
large plasmids. All steps were carried out at room temperature unless 
otherwise stated. An overnight preculture was used to innoculate 
500 ml of L broth. Cells were grown to a density corresponding to a 
reading of 50-100 Klett units, and harvested by centrifugation. The 
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cells were was~ed twice in EM lacking glucose and resuspended in 49 
ml of 0.05 M Tris-HCl, pH 8.0. After thorough mixing, 1.0 ml of 1.0 M 
EDTA, pH 8.0 was added to the cell suspension. A solution of lysozyme 
in TE buffer (0.05 M Tris~HCl, 0.02 M EDTA, pH 8.0) was added to 
achieve a final concentration of 200 g/ml and the mixture was in-
cubated for 5 min in a 37 C waterbath. Carefully, 2.5 ml of 20X SDS 
solution was added to make 1% final concentration. Incubation at 37 C 
was resumed until a clear lysate of high viscosity was obtained 
(10-60 min). 
The lysate was sheared until it flowed evenly by several 
passages through an 18 guage hypodermic needle attached to a 50 cc 
syringe. The DNA was denatured by adjusting the pH of the sheared 
lysate to 12.1 - 12.4 by the dropwise addition of 3N NaOH with con-
tinuous stirring on a magnetic stir plate. After 10 min of mixing, 
the pH of the solution was brought to approximately 8.5 by the rapid 
addition of 2.0 ~ Tris-HCl, pH 7.0. Stirring was continued for 3 min. 
The lysate was adjusted to a final concentration of 3% (w/v) NaCl 
by the addition of solid salt. An equal volume of redistilled phenol 
equilibrated with 3X SSC (0.15 ~ NaCl, 0.015 ~ trisodium citrate) 
was added and the lysate mixture was stirred for 7 min fast enough to 
mix the phases. The lysate was centrifuged at 10,000 rpm for 10 min 
and the aqueous phase removed to a clean flask without disturbing the 
precipitate at the interphase. A second extraction using an equal 
volume of chloroform-isoamyl alcohol (24:1 v/v) proceeded likewise. To 
the aqueous phase a 0.02 volume of 1.0 M sodium phosphate buffer was 
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added followed by the addition of 0.025 volume of 1.0 M magnesium 
chloride. The ~olution was well mixed by swirling the flask. A 0.7 
volume of cold (-20Cl 95% ethanol was added while swirling the flask. 
If the solution did not become cloudy the magnesium chloride addition 
was repeated. The lysate was stored at -20C for 1-24 h. Precipitated 
DNA was collected by centrifugation for 10 min at 10~000 rpm, re-
dissolved ina,minimal volume (less than 5 ml) of 0.25 ~ EDTA, pH 8.0 
and dialyzed against TES buffer for 24 h. The plasmid DNA was further 
purified by dye-bouyant-density centrifugation as described below. 
Alternately, following the chloroform-isoamyl alcohol extraction, 
the aqueous phase was brought to a final concentration of 0.3 M 
sodium acetate by the addition of 0.1 volume of 3.0 M stock solution. 
Twice the volume of cold ethanol (-20C) was added to the solution which 
was stored at -20C overnight. The precipitated DNA was collected by 
centrifugation at 12,000 rpm for 20 min at -5 C. After allowing the 
centrifuge tube to drain, the pellet was resuspended in 2.0 m1 TES 
buffer and prepared for CsCl-EtBr centrifugation. 
d. Humphreys Method 
Early in this work concentration of DNA from large lysates was 
achieved through use of polyethylene gycol (PEG) precipitation of 
cleared lysates (46} prepared from 500 ml cultures. After the addition 
of NaCl to achieve a final concentration of 0.5 M, the lysates were 
adjusted to 10% PEG (w/v). The mixture was dissolved by swirling the 
flask, covered and stored overnight at 4 C. Centrifugation at 10,000 
rpm for 10 min pelleted the DNA. After discarding the supernatant~ 
the pellet was resuspended in a minimal volume of TES buffer and 
purified by CsCl-EtBr centrifugation. 
10. Agarose Gel Electrophoresis 
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Plasmid DNA prepared by the Guerry-Meyers method described above, 
was subjected to electrophoresis in 0.7% agarose (SeaKem, Inc.) dis·· 
solved in Tris borate buffer (89.0 mM Tris base, 2.5 mM EDTA, 89 mM 
boric acid) (71). To each sample, 5 ~1 of dye solution (0.07% 
bromophenol blue, 7.0% SDS, 33% glycerol in dH20) was added prior to 
electrophoresis. A horizontal slab gel apparatus (20 x 20 em) with 
wells 1 mm x 12 mm x 7 mm deep was used. The electrophoresis was 
carried out at 60 mA, 120 V for 3-4 h or until the dye had travelled 
10-12 em. The gel was placed in a solution of ethidium bromide 
{0.5 ~/ml in dH2o) and stained for 15 min. The DNA bands, illuminated 
by a near UV (366 nm) transilluminator (UV Products, Inc.) were 
photographed with a Polaroid MP4 camera using type 57 film and UV 17 
and type 21 filters. 
11. Cesium-Chloride-Ethidium Bromide Density Centrifugation 
Purification of plasmid DNA was schieved by subjecting the par-
tially purified DNA to cesium chloride-ethidium bromide (CsCl-EtBr) 
equilibrium density gradient centrifugation (28, 132). In the dark, 
7.0 ml of the DNA in TES buffer was added to 7.3 g CaCl. To this 
0.6 ml EtBr (10 mg/ml in TES buffer) was added and the refractive 
index adjusted to 1.392. If PEG or sodium acetate was used to pre-
cipitate the DNA, the refractive index was adjusted to 1.3925 or 1.3940 
respectively, The solution was placed in a polyallomar centrifuge 
tube (Beckman), topped with mineral oil, capped and centrifuged to 
equilibrium (48 - 72 h, Beckman L-4 or L-5-65 ultracentrifuge, 40 
rotor, 35,000 rpm, 20 C). 
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Following centrifugation, bands of DNA were visualized using 
ultraviolet light. The larger upper band contained linear chromosomal 
DNA, and the smaller lower band contained the supercoiled plasmid DNA 
which bands at a greater density than the linear form. The plasmid 
DNA was removed either by side puncture of the tube using an 18 guage 
needle attached to a 3 cc syringe or by aspiration of the oil and 
upper band by mild vacuum and removing the remaining plasmid band 
using a pasteur pipette with the tip cut off. Ethidium bromide was 
removed by extracting the DNA solution several times with isopropyl 
alcohol saturated with 20X sse. Cesium chloride was removed by over-
night dialysis against TES buffer. In most cases the plasmid DNA was 
repurified by a second centrifugation in CsCl-EtBr. 
Cesium chloride-ethidium bromide density gradients containing 
(~)-DNA were fractionated by bottom puncture of the centrifuge tube. 
Fractions containing 15-18 drops each (approximately 0.15 ml) were 
tested for the presence of radioactivity by spotting a S ~1 sample 
of each onto Whatman filter strips. The strips were dried, washed 
twice in 5% trichloroacetic acid (TCA) for 5 min, and twice in 95% 
ethanol for 5 min. The strips were cut to divide fraction samples 
and each was placed into a scintillation vial containing 10 ml 
scintillation cocktail (Toluene-Liquifluor, NEN). Radioactive counts 
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were determined in a Packard Tri-Carb Liquid Scintillation Spectrometer. 
When plasmid DNA was present peaks were seen. The first dense peak 
containing the plasmid DNA fractions was collected and subjected to a 
second CsCl-EtBr centrifugation for further purification. 
12. Sucrose Gradients 
a. Alkaline Sucrose Gradients 
Solutions of (3H)-labelled plasmid DNA (0.1 ml) were layered 
onto 5.0 ml 5-20% linear alkaline sucrose gradients (0.5 M NaCl, 0.3 M 
NaOH, 0.2 M EDTA, pH 8.0) in cellulose nitrate centrifuge tubes 
(Beckman). The gradients were centrifuged for 30 min at 35,000 rpm 
(Beckman L-5-65 ultracentrifuge, SWSO.l rotor). Approximately 35 
fractions (7 drops each) were collected from the bottom of the tube 
directly into scintillation vials containing 1.0 m1 of 1 ~ phosphate 
buffer and 10 ml Beckman Redi-Solv-scintillation cocktail was added 
to each vial. Each sample was counted for radioactivity as described 
above. 
b. Neutral Sucrose Gradients 
For analytical purposes, samples of (3H)-DNA were overlayered 
onto 5 ml linear neutral sucrose gradients (0.55 M NaCl, 0.05 ~ 
Tris-HCl, 0.005 ~ EDTA, pH 8.0). The gradients were centrifuged for 
120 min at 35,000 rpm (Beckman L-5-65 ultracentrifuge, SW50.1 rotor), 
fractionated, and radioactivity determined as described above, except 
for the exclusion of the 1.0 ml of phosphate buffer. 
Preparative linear 5-20% neutral sucrose gradients were used to 
separate and purify plasmid DNA. Samples of DNA (1.0 ml) were layered 
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onto 11 m1 5-20% neutral sucrose gradients in 12 ml polyallomar 
centrifuge tubes and centrifuged in a SP269 swinging bucket rotor at 
30,000 rpm, 140 min in an IEC-B60 centrifuge. A bottom dripper was 
used to divide the gradients into 18 drop fractions. A 5 ~1 sample 
of each fraction was spotted onto filter strips, precipitated with TCA, 
rinsed in 95% ethanol, dried and counted as previously described. 
Fractions containing plasmid DNA were pooled, dialyzed against TES 
buffer and recentrifuged in 12 m1 neutral sucrose gradients. 
13. Quantitation of DNA 
Samples of DNA were quantitated by determining their absorbancy 
at 260 nm. Plasmid DNA samples were diluted 1:20 in O.lX sse and 
placed in quartz spectrometer tubes. The absorbance at 260 nm, de-
termined using a Gilford UV spectrometer, was equal to the concentra-
tion of the undiluted DNA in mg/ml. 
14. Electron Microscopic Analysis of Plasmid DNA 
A modification of the Kleinschmidt technique (51) was used to 
prepare the DNA for examination in the electron microscope (EM). To 
prepare the 400 mesh EM grids, they were first placed on a stainless 
steel screen set in a large funnel containing double distilled 
deionized water (ddH2o). A drop of parlodian dissolved in ethanol 
was allowed to spread over the water surface and was then lowered onto 
the screen by slowly releasing the water through the bottom of the 
funnel. The parlodian coated grids were incubated at 60 C for 15 min 
and cooled. Prior to each use, a fresh stock of spreading solution 
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contain~g 5 ~1 of 1,0 M ammonium acetate, 10 ~1 cytochrome C (10 mg/ml 
in ddH20) and 40 ~1 DNA sample (approximately 1 ~g) in 0,01 M Tris-Hcl 
pH 8,0 was prepared, The stock staining solution, which contained 
0.05 M HCl and 0,05 M uranylacetate in 95% ethanol, was ~ade fresh 
each week. 
The DNA was spread using an acid-cleaned microscope slide soaked 
in hypophase (0.25 M ammonium acetate). The slide was partially sub-
merged in a petri dish containing hypophase and allowed to dry. A 
50 ~1 drop of spreading solution containing the DNA was gently deposited 
onto the slide one-eighth inch above the meniscus and allowed to spread 
over the hypophase for 60 sec. By touching the film side of the grid 
to the surface of the hypophase near the slide, a drop-containing DNA 
was collected on the grid. The grid was immediately submerged in the 
staining solution for 30 sec, washed in isopentane for 10 sec, and air 
dried. 
Contrast was enhanced by rotary shadowing using 3 em of 80:20 
platinum:palladium 8 mil wire wrapped around a tungston wire of 0.025 
em diameter. The grids were viewed through the RCA electron microscope 
at Hines V. A. Hospital. 
The images of the electron-micrograph negatives were projected 
through a photographic enlarger onto newsprint and traces. Projection 
enlargement was determined by projecting a centtmeter rule at the same 
focal length. The contour length of each molecule was determined by at 
least two measurements with a map ruler. A standard EM grid (#1002 
having 2159 intervals per mm) was used to determine the magnification 
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of the electron microscope. A typical grid photograph measured 27 mm 
per 8 intervals, thus the magnification of this grid was calculated to 
be 7287. The measured contour length of the molecule divided by the 
total magnification (7287 X the magnification of the projected image) 
equaled the true length of the plasmid molecule in microns. Molecular 
mass in daltons was calculated by multiplying the length of the 
molecule by the constant 2.07 (59). 
CHAPTER III 
RESULTS 
1, Resistance Phenotype 
Proteus mirabilis 2138 is a clinical isolate from the urine of a 
patient ~t Hines Veterans Administration Hospital at Hines, Illinois. 
The resistance to various antibacterial agents of this strain was 
determined by the Kirby-Bauer disk diffusion technique as described 
in Materials and Methods. The strain was found to be resistant to 
ampicillin, carbenicillin, gentamicin, tobramycin, neomycin, kanamycin, 
streptomycin, tetracycline, colistin, cephalothin and nitrofurantoin, 
and sensitive to naladixic acid, rifampicin, and chloramphenicol. 
2. Transmissibility 
To determine if resistance to beta-lactam and aminoglycoside anti-
biotics in strain 2138 resided on a conjugable plasmid, a mating using 
Escherichia £211 J53-1 as recipient was performed. To select against 
the Proteus donor, the genetically characterized strain J53 was made 
resistant to rifampicin (200 ].lg/ml) by selection on medium containing 
increasing concentrations of that drug as described in Materials and 
Methods. This strain, J53-1, was used in subsequent experiments. 
Minimal medium plates containing methionine, proline, rifampicin (200 
j.lg/ml), and either carbenicillin (100 ].lg/ml) or gentamicin (50 J.lg/ml) 
were used to select transconjugates, Use of the standard overnight 
broth conjugation procedure described in the Methods section failed to 
demonstrate transfer of antibiotics resistance to the recipient. 
4.7 
to increase cell to cell contact and hence the probability of 
conjugation, the donor and recipient cells were concentrated onto 
Millipore filters as described (see Materials and Methods). Using 
this method transfer of antibiotic resistance traits was achieved. 
48 
The frequency of conjugation on filteiS, calculated as the number of 
transconjugates per input donor cells, averaged 1.4 x lo-2 with a 
range of 1.3 to 1.5. There was no significant difference in frequency 
of transfer between cells selected on carbenicillin-c9ntaining plates 
and those selected on gentamicin-containing plates. 
Ten strain J53-l transconjugate clones, numbered J53-l(Pl)-
J53-l(Pl0), were checked for purity and found to be auxotrophic for 
methionine and proline. To determine if more than one resistant 
trait had been transferred, antibiotic disk diffusion tests were per-
formed on five transconjugate clones from each of the two selective 
media employed. The results, shown in Table III, confirm that multiple 
resistance had been transferred to all clones tested. Resistance to 
Ap, Cb, Gm, Tm, Km, Sm, and Cl was transferred to both groups of 
transconjugates. However, in no case was resistance to Nm, Tc or Cs 
ever observed to transfer. Given the cross-reactivity of most animo-
glycoside inactivating enzymes, it is interesting to note that resis-
tance to kanamycin was transferred, but not to that of the closely 
related antibiotic, neomycin. 
To achieve a more precise measure of the level of resistance to 
these antibiotics, the minimal bactericidal concentrations (MBC) were 
determined as described in Materials and Methods. The MBCs of am-
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Table III, 
Antibiotic resistance patternsa of donor, recipient 
and transconjugate strains. 
Strain Antibioticb No. of isolates 
P. mirabilis 2138 Ap Cb Gm Tm Km Sm Cl Tc Cs Nm 1 
E. coli J53-l ~ 1 
E. ~ J53-l(Pl) Ap Cb Gm Tm Km Sm Cl Rm 10/10 
a Determined by the disk diffusion technique (69) 
b Ap - ampicillin, Cb - carbenicillin, Gm - gentamicin, Tm - tobra-
mycin, Nm - neomycin, Km - kanamycin, Sm - streptomycin, Tc -
tetracycline, Cs - colistin, Cl - cephalothin, ~ - rifampicin. 
50 
picillin, gentamicin, tobramycin, neomycin, kanamycin and strepto-
mycin were determined for strains 2138, J53-l and the 10 transcon-
jugates. The results, shown in Table IV, reveal high levels of re-
sistance to Ap, Cb, Gm, Tm and Sm for both the donor strain 2138 and 
the 10 transconjugate clones. Values were very low for the recipient 
strain J53-l. Variations of one tube dilution were seen in the MBC 
values of the trarisconjugates. It is uncertain why the MBC of Sm for 
2138 and the transconjugate strains differ. It is possible that the 
donor has inherent resistance properties which are not transferred. 
A difference of one tube dilution is not thought to be significant 
(37). Resistance to high concentrations of antibiotics is indicative 
of R plasmid-mediated resistance (76). Again the lack of transfer of 
neomycin resistance was clearly evident, despite the high level of re-
sistance in the donor. 
3. Isolation of Extrachromosomal DNA 
The fact that resistance to high concentrations of antibiotics 
could be transferred to a sensitive strain, indicated that an R plasmid 
was involved. Definitive proof of the existance of plasmids can be 
obtained through isolation of the plasmid DNA by ultracentrifugation 
(91). To determine if drug resistance was conferred by an R plasmid_, 
the Proteus donor, J53-l recipient and J53-l(Pl) transconjugate were 
analyzed for plasmid DNA using the Helinski method for partial purifi-
cation of plasmid DNA followed by cesium chloride-ethidium bromide 
density centrifugation (see Materials and Methods). The gradients were 
centrifuged for 72 h at 32,000 rpm as described. Viewed under UV 
illumination, satellite DNA bands were visible in the gradients from 
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Table IV. 
a Minimal Bactericidal Concentrations for donor, recipient 
and transconjugate strains. 
Strain MBC ( llg/ml)b 
Ap Cb Gm Tm Km Sm Nm 
P. mirabilis 2138 >2000 >2000 500 500 >1000 >2500 >2000 
E. coli J53-1 ~8 <8 2 <8 <8 20 
Transconjugatesc 
J53-l(Pl) >2000 >2000 500 500 1000 625 
J53-l(P2) >2000 >2000 250 250 1000 625 
J53-l(P3) >2000 >2000 250 500 500 313 
J53-l(P4) >2000 >2000 250 250 1000 313 
J53-l(P5) >2000 >2000 250 250 500 313 
J53-l(P6) >2000 >2000 250 250 1000 313 
J53-l(P7) >2000 >2000 250 250 500 313 
J53-l(P8) >2000 >2000 250 500 500 313 
J53-l(P9) >2000 >2000 250 500 1000 313 
J53-l(Pl0) >2000 >2000 250 500 1000 313 
a Determined by tube dilution technique. 
b Abbreviations are as noted in Table III. 
c J53-l(Pl) - J53-l(P5) selected on medium containing 50 llg/ml Gm, 
J53-l(P6) - J53-l(Pl0) selected on medium containing 100 llg/ml 
Cb as described in the Results section. 
<8 
<8 
<8 
<8 
<8 
<8 
<8 
<8 
<8 
<8 
<8 
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the donor and transconjugate, but not in the recipient (data not shown). 
re isolate R plasmid DNA, cells were grown in the presence of 
(la)-thymtdtne as described in the Methods section, lysed by the 
Helinski method and the partially purified radiolabelled DNA was 
centrifuged to equilibrium in CsCl-EtBr gradients. The gradients were 
fractionated from the bottom and 0.01 ml samples of each fraction were 
spotted on filter strips. Following TCA precipit~tion, radio-
activity was determined as described in Materials and Methods. Pro-
files of the gradients, shown in Figure l, demonstrate the presence of 
dense satellite DNA in strains 2138 and J53-l(Pl), where none could be 
seen in strain J53-l. The presence of the two peaks in the CsCl-EtBr 
gradient profile confirmed the visual data described above. The con-
comitant acquisition of antibiotic resistance and extrachromosomal DNA 
provided evidence for the existence of a conjugable R plasmid in P. 
mirabilis 2138. 
4. Molecular Characterization of the Plasmid 
a. Determination of Plasmid Size 
The most accurate molecular mass determinations of plasmid 
molecules have come from measurement of the contour length of the mole-
cules taken from electron micrographs (43). Preparative (500 ml) 
cultures of strains 2138 and J53-l(Pl) were lysed according to the 
Helinski method. To enhance the yield and concentrate the DNA, the 
lysates were precipitated with PEG as described in Materials and 
Methods, and centrifuged to equilibrium in CsCl-EtBr gradients. The 
plasmid bands were extracted from the gradients and purified by a 
Figure 1. Cesium chloride-ethidium bromide 
centrifugation profiles of DNA isolated from donor 
recipient and transconjugate strains. Helinski 
cleared lysates of P. mirabilis 2138, E. coli 
J53-l and E. coli J53-l(Pl) were centrifuged to 
equilibrium at 20 C, using a fixed angle 40 rotor 
in a Beckman L5-65 ultracentrifuge for 60 h at 
35,000 rpm. The gradients were fractionated from 
the bottom and radioactivity determined as de-
scribed in Materials and Methods. (A) P. mirabilis 
2138. (B) E. coli J53-l (C)!· coli J53-l(Pl). 
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second·centrifugation in CsCl-EtBr. The purified plasmid DNA was 
removed and prepared for electron microscopy using the method of 
Klei.riscbm:ldt as desct':lbed in the Materials and Methods section • 
. 
iypical electronmicrographs are shown in Figure 2. Contour 
length measurements revealed the presence of at least two size classes 
of molecules in strain 2138 and only one in strain J53-l(Pl). The mole-
cu1ar mass distributions of the plasmids are shown in Figure 3. Plas-
mids from strain 2138 were found to be 4.96 ± 0.05 and 25.82 + 2.82 
megadaltons (Figure 3A). The single size class found in strain J53-l 
(Pl) measured 89.76 + 2.23 megadaltons (Figure 3B). 
Existence of dissociated R plasmids in Proteus species has been 
well documented (11, 36, 93, see Introduction). If this were the case 
in strain 2138, the large plasmid found in J53-l(Pl) could be a trimer 
of the 27 megadalton plasmid found in strain 2138. Further elucidation 
of the molecular nature of these plasmids was needed to determine the 
relationship between them. 
b. Neutral Sucrose Gradients 
To determine whether the small and large Proteus plasmids 
represented r-determinants and RTF replicons respectively, it would 
be necessary to isolate them individually and use the DNA to transform 
sensitive strains. Neutral sucrose gradients provide an effective 
means of separating plasmids on the basis of their molecular mass, and 
were used to separate the plasmids present in strains 2138 and J53-l(Pl) 
Large cultures {500 ml) of strains 2138 and J53-l(Pl) were grown 
as described previously. Additionally, 30 ml cultures of each strain 
Figure 2. Electronmicrographs of plasmids isolated 
from donor and transconjugate strains. The Helinski 
lysis technique followed by dye-bouyant density 
centrifugation was used to isolate DNA from P. 
mirabilis 2138 and E. coli J53-l(Pl). The isolated 
DNA was prepared for electron microscopy by the 
Kleinschmidt method (see Materials and Methods 
section). (A) P. mirabilis 2138 (B) E. coli J53-l(Pl) 
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Figure 3. Molec'\llar mass distributions of plasmid 
molecules isolated from P. mirabilis 2138 and E. 
coli J53-l(Pl). Plasmid-DNA was isolated using the 
Helinski cleared lysate technique, purified by 
equilibrium gradient centrifugation in cesium chlor-
ide-ethidium bromide and prepared for electron 
microscopy using the method of Kleinschmidt (see 
Materials and Methods). Contour length measurements 
of electron micrographs were converted to molecular 
mass using the equation: Mass • 2.07 x llm. (A) 
P. mirabilis 2138 plasmid DNA. (B) E. coli J53-l(Pl) 
plasmids DNA. - --
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were grown in the presence of (3H)-thymidine as described in Materials 
and Methods. The cells from both cultures were combined and lysed by 
the Helinski method followed by PEG precipitation. A 0.1 ml sample of 
the isolated plasmid DNA, twice purified in CsCl-EtBr gradients, was 
overlayed onto a 5 ml analytical 5-20% linear neutral sucrose gradient 
and centrifuged at 35,000 rpm for 150 min (see Materials and Methods 
section). The sucrose gradient profiles are shown in Figure 4. As 
expected the presence of one fast sedimenting plasmid was seen in the 
profile of plasmid DNA from strain J53-l(Pl) (Figure 4A). However, the 
profile of plasmid DNA from strain 2138 (Figure 4B) was not as clear. 
At least three peaks could be distinguished in the gradient, but the 
data was irreproducible. The existenance of several diffuse peaks 
were seen in later gradients. 
c. Alkaline Sucrose Gradients 
Initially it was thought that the poor resolution of the 
Proteus gradient was due to breakage during the extraction and iso-
lation, resulting in nicked open circular or broken linear fragments 
of the plasmid DNA. These species would sediment at different rates 
and could account for multiple, nonreproducible peaks in neutral 
sucrose gradients. Alkaline sucrose gradient sedimentation causes 
denaturation of nicked and linear forms of DNA. Since supercoiled 
DNA will sediment 3.8 times faster than the denatured forms in alka-
line sucrose gradients (pH 12.5) (100), the number and size of 
resident plasmid species within the Proteus- strain could be determined. 
Radiolabelled plasmid DNA from strains 2138 and J53-l(Pl) was isolated 
Figure 4. Neutral sucrose gradient profiles of 
plasmid DNA from strains J53-l(Pl) and 2138. The 
DNA samples were isolated by the Helinski method, 
twice purified in cesium chloride-ethidium bromide 
gradients and overlayered on a 5-20% linear neutral 
sucrose gradient in a SW50.1 rotor. The gradients 
were centrifuged at 20 C, 35,000 rpm for 2.5 h as 
described in Materials and Methods. (A) Strain 
J53-l(Pl). (B) Strain 2138. 
61 
I • 
-
~-OlxX:J/Wd:l 
.( 
• • • • 
• - • - = -
~-OlxX:J/Wd:l 
62 
-
-1 
• 
• &U 
ID 
~ 
::) 
z 
z 
0 
9 
• II. 
• &U 
CID 
~ 
::) 
z 
z 
0 j: 
~ 
• II. 
using the Cur;r;t.er method and subjected to alkaline sucrose gradient 
sedimentation as described in Materials and Methods. The gradient 
profiles from strain -2138, shown in Figure 5, revealed the presence 
of the two plasmids seen in electronmicrographs as well as the 
presence of a third, fast sedimenting DNA-species. This suggested that 
a third plasmid was present in strain 2138, but had not been isolated 
in quantity using the Helinski lysis technique. 
d. Isolation of the Large Plasmid 
The Currier plasmid isolation technique was employed for its 
usefulness in isolating large plasmids having molecular mass in excess 
of 60 megadaltons (15). Large (500 ml) cell cultures were combined 
with 30 m1 cultures of cells grown in the presence of (3H)-thymidine, 
lysed and subjected to the Currier plasmid isolation technique as 
described in Materials and Methods. Dye-bouyant centrifugation of the 
DNA revealed the presence of satellite bands from lysates of strains 
2138 and J53-l(Pl), but not in strain J53-1. This reaffirmed that 
plasmid transfer had occu~red between donor and recipient strains. 
It was found that a modification of the Currier method (see Materials 
and Methods) using sodium acetate and ethanol to precipitate the DNA 
greatly enhanced the yield of plasmid DNA. Figure 6 shows the CaCl-
EtBr gradient profiles of strain 2138 and J53-l(Pl) using this 
technique, The plasmid fractions were pooled, rebanded in CsCl-EtBr 
gradients and prepared for sucrose gradient sedimentation, 
rhe analytical sucrose gradient sedimentation profiles of plasmid 
DNA from strains 2138 and J53-l(Pl) isolated using the modified 
Figure 5. Alkaline sucrose gradient profiles of 
plasmid DNA from strains 2138 and J53-l(Pl). The DNA 
samples were isolated by the Currier method and puri-
fied by centrifugation in cesium chloride-ethidium 
bromide density gradients. The isolated plasmid DNA 
samples were layered on 5-20% alkaline (pH 12.0) 
sucrose gradients and centrifuged in a SW50.1 rotor, 
35,000 rpm for 0.5 h. Fractions were collected from 
the bottom and analyzed as described in Materia~s and 
Methods. (A) Strain J53-l(Pl). (B) Strain 2138. 
64 
65 
= 
• -
-
r;-OL xX:J/Wd:l 
~OLxX:I/Wd:l 
itgure 6, Cesium chloride-ethidium bromide profiles 
of purified plasmid DNA from strains 2138 and J53-l(Pl). 
Plasmid DNA was isolated using the Currier technique 
and purified by cesium chloride-ethidium bromide 
density centrifugation. The CsCl-EtBr gradients were 
centrifuged, fractionated and analyzed as described 
for Figure 1. (A) Strain J53-l(Pl). (B) Strain 2138. 
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Currier technique are shown in Figure 7. One peak was seen in the 
strain J53-l(Pl) gradient (Figure 7A), while three, clearly distin-
guishable peaks were seen in the strain 2138 plasmid DNA gradient 
(Figure 7B). The slowest sedimentating peak was labelled peak I, the 
middle as peak II, and the fastest as peak !II. 
e. Separation of Proteus plasmids 
Preparative neutral sucrose gradients were employed to 
isolate and separate the three Proteus plasmids in quantity. The 
cells were g~pwn as before and subjected to the modified Currier 
plasmid isolation technique. Plasmid DNA was centrifuged in CsCl-
EtBr gradients twice and prepared for neutral sucrose gradient sedi-
mentation. A 1.0 sample of purified DNA was overlayered on a 12 ml 
linear 5-20% neutral sucrose gradient, and centrifuged at 30,000 rpm 
in a SP269 swinging bucket rotor for 140 min (see Materials and 
Methods). The gradients were fractionated by bottom puncture and 
radioactivity in each fraction determined as described. Fractions of 
each plasmid peak were pooled and centrifuged separately in a second 
sucrose gradient. The three Proteus plasmids were collected as 
described in Materials and Methods and used for further study. 
f. Determination of Plasmid Size 
Electron micrographs of the largest (peak III) Proteus 
plasmid isolated by neutral sucrose gradient sedimentation, were taken 
and used to size this plasmid species. A typical picture is shown in 
Figure 8. The molecular mass, calculated from the contour length 
Figure 7. Neutral sucrose gradient profiles of plasmid 
DNA isolated from strains 2138 and J53-l(Pl). Plasmid 
DNA isolated by the Currier method was purified by two 
centrifugations in cesium chloride-ethidium bromide 
gradients, collected and prepared for neutral sucrose 
gradient sedimentation as described in the Materials 
and Methods section. The 12 ml sucrose gradients (5-20%) 
were centrifuged in a SP269 rotor at 30,000 rpm for 140 
min at 20 C and fractionated by bottom puncture. Radio-
activity was determined as described in Materials and 
Methods. (A) Strain J53-l(Pl). (B) Strain 2138. · 
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Figure 8. Electron micrographs of !· mirabilis 2138 
peak III plasmid DNA. Proteus plasmid DNA was isolated 
using the Currier technique and purified by cesium 
chloride-ethidium bromide centrifugation. The Proteus 
plasmids were separated according to mass centrifugation 
in neutral sucrose gradients as described in Materials 
and Methods. Peak III plasmid DNA was prepared for 
viewing under the electron microscope using a modifi-
cation of the Kleinschmidt method as described in 
Materials and Methods. A typical molecule is shown here· 
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measurements, was found to be close to that of the J53-l(Pl) plasmid. 
The distribution of the measured plasmid molecule is shoWn in Figure 
9. The average molecular mass of the peak III plasmid was determined 
to be 90.33 + 2.45 megadaltons. Compared to a value of 89.87 + 2.23 
megadaltons obtained for the plasmid isolated from J53-l(Pl), it was 
concluded that these were the same plasmid species. 
Electronmicrograph measurements of peak I and peak II plasmid 
DNA were consistent with previous measurements of strain 2136 plasmid 
DNA. Peaks I and II plasmid DNA averaged 4.95 and 27.1 megadaltons 
respectively. It was concluded that these were the same plasmid 
series seen in Figure 2. 
g, Agarose Gel Electrophoresis 
Agarose gel electrophoresis has been used to detect and estimate 
plasmid DNA species ranging in molecular mass from 6.0 x 105 to 
95 x 106 daltons (78). Isolated plasmid DNA from strains 2138 and 
J53-l(Pl) were electrophoresed in horizontal agarose gels as described 
in the Materials and Methods section. The gel, pictured in Figure 10, 
reveals the presence of three plasmid species in Proteus and one in 
strain J53-l(Pl). Slots A and H contain total~· mirabilis 2138 
plasmid DNA and clearly reveal the presence of 3 plasmid species. The 
plasmid DNA from peak I, seen in slots B and C aligns with the 
fastest migrating plasmid in slot A. Above the chromosomal band in 
slot A is the middle sized plasmid which migrates with the peak II 
plasmid in slot D. The peak II plasmid in slot E is not visible, The 
slowest migrating plasmid in slot A aligns with the peak III plasmid 
Figure 9. Molecular mass distribution of peak III 
Proteus plasmids. Plasmid DNA isolated from strain 2138 
by the Currier method was twice centrifuged in cesium 
chloride-ethidium bromide gradients and purified in 
neutral sucrose gradients as described in the Materials 
and Methods section. The DNA was prepared for electron 
microscopy by a modification of the Kleinschmidt method. 
Molecular mass was determined as for Figure 3. 
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Figure 10. Agarose gel electrophoresis of purified 
plasmid DNA isolated from strains 2138 and J53-l(Pl). 
Plasmid DNA from strains 2138 and J53-l(Pl) was iso-
lated as for Figure 9. The purified plasmid DNA was 
subjected to electrophoresis in a horizontal 0.7% 
agarose gel for 4 h at 120 V. The gel was stained 
with ethidium bromide (0.5 ~g/ml) for 15 min. Pictures 
were taken with a Polaroid MP4 camera using type 57 
film under UV illumination. (A) Total strain 2138 
plasmidDNA. (B and C) Isolated peak I plasmid DNA. 
(D and E) Isolated peak II plasmid DNA. (F) Isolated 
peak III plasmid DNA. (G) Isolated J53-l(Pl) plasmid 
DNA. (H) Total strain 2138 plasmid DNA. 
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in slot F and the J53-l(Pl) plasmid in slot G. This supports the con-
tour length measurements which showed that the peak III plasmid and 
the J53-l(Pl) plasmid were the same size. 
5. Proof that the Peak III Plasmid Confers Aminoglycoside Resistance 
a. Transformation Experiment 
A transformation experiment was devised to determine if the 90 
megadalton plasmid (peak III) was responsible for resistance to the 
beta-lactam and aminoglycoside antibiotics. Individual plasmid DNA 
species isolated from strain 2138 by CsCl-EtBr centrifugation of 
Currier lysates and separated in neutral sucrose gradients were used 
as the transforming elements. A rifampicin resistant clone of 
Escherichia coliC, strain Cl200-l (his, met), was selected as re-
cipient because it lacks a restriction system. The transformation 
method of Lederberg and Cohen was followed as described in the 
Materials and Methods section, and transformants were selected on 
plates containing either 25 ~g/ml gentamicin or 100 ~g/ml carbeni-
cillin. 
Only two of the individual plasmid DNA species isolated from 
Proteus mirabilis 2138 were found to be capable of transforming strain 
Cl200-l to antibiotic resistance. Both the peak I (4.96 Mdal) and 
peak III (90.3 Mdal) plasmids were capable of transforming strain 
Cl200-l to carbenicillin resistance. However, only the latter was 
capable of transforming strain Cl200-l to gentamicin resistance. No 
gentamicin or carbenicillin resistant transformants could be isolated 
79 
using the peak II (26.8 Mdal) plasmid. The frequency of transformation, 
calculated as the number of transformants per imput donor cell, was de-
termined for each plasmid species. Transformation of Cb resistance 
occurred at a much higher frequency using the peak I plasmid donor 
(7.2 x 10-4) than the peak III plasmid donor (7.3 x 10-8). Trans-
formation of gentamicin resistance occurred at a frequency of 3.8 x 
lo-8. The ability of the smaller plasmid to transform strain Cl200-l 
at a higher frequency than the large plasmid was thought to be either 
a reflection'of the size difference between the two plasmids, an 
effect of concentration of donor DNA, or a combination of both factors. 
Escherichia coli Cl200-l transformants of each plasmid species 
were cloned, tested for purity and subjected to antibiotic disk dif-
fusion testing to determine if additional antibiotic resistance traits 
had been transferred. Ten clones from each selection were tested and 
the results are shown in Table V. Peak I transformante demonstrated 
resistance exclusively to the beta-lactam antibiotics. Peak III 
transformante selected on medium containing either gentamicin or 
carbenicillin showed identical resistance patterns including resis-
tance to Ap, Tm, Km., Sm and Cl in addition to Gm and Cb. 
b. Electrophoresis of Plasmid DNA 
To detect the presence of the plasmid DNA in the trans-
formants and to determine if this was the same size species as the 
donor plasmid, the strain Cl200-l transformants were lysed, and the 
partially purified plasmid DNA samples were subjected to agarose gel 
electrophoresis as described in Materials and Methods. The results, 
Table V. 
Transformation of !• coli to antibiotic resistance using 
a P. mirabilis plasmid DNA • 
Strain Transforming 
DNAb 
Selection 
P. mirabilis 2138 
E. coli Cl200-l 
---
Transformante 
Cl200-l peak l Ap 
Cl200-1 peak I Gm 
Cl200-l peak II Ap 
Cl200-l peak II Gm 
Cl200-l peak III Ap 
Cl200-l peak III Gm 
a Determined by disk diffusion technique (69). 
b Transforming DNA as described as in Figure 7. 
c Abbreviations as described in Table III. 
Resistance patternc 
Ap Cb Gm Tin Km Sm Cs Cl Nm Tc 
Ap Cb Cl 
No transformante detected 
No transformants detected 
No transformante detected 
~CbGmTmKm~ cr 
~CbGmTmKm~ cr 
00 
0 
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pictured ~n Figure 11, reaff~rm that the peak III plasmid was the con-
jugable R plasmid. The peak I transformants are shown to have only 
one plasmid which migrates with the 4.95 Mdal plasmid found in strain 
2138. The largest Proteus plasmid migrated with that found in the 
peak III transformants of strain Cl200-l. Estimates of the molecular 
masses of these plasmids, claculated from their migratory distance in 
the gels are consistant with those calculated from contour length 
measurements. 
The transformation of multiple resistance by the 90.3 Mdal (peak 
III) plasmid gave conclusive evidence that this was the plasmid carry-
ing the aminoglycoside determinants and was the conjugable R plasmid 
in P. mirabilis 2138. 
6. Nomenclature 
To conform with other work being done in our laboratory and with 
uniform nomenclature as proposed by Novick et al. (83), the plasmids 
found in P. mirabilis 2138 were redesignated as follows: the 4.95 
Mdal (peak I) plasmid has been renamed pFL10020; the 26.8 Mdal (peak 
II) plasmid has been renamed pFL10030; and the 90.3 Mdal (peak IIIO 
plasmid has been renamed pFLlOOlO. The transconjugate !· coli J53-l(Pl) 
has been redesignated as J53-l(pFL10010), the peak III transformants 
have been designated as Cl200-l(pFL10010) and the peak I transformants 
as Cl200~l(pFL10020). Transconjugates from other matings were desig-
nated by the recipient strain followed with the (pFLlOOlO) designation. 
tn summary, then, the plasmid pFLlOOlO has been shown to confer 
Figure 11. Agarose gel electrophoresis of plasmid DNA 
isolated from E. coli transformants. Peak III purified 
plasmid DNA, isolated from strain 2138, was used to transform 
E. coli Cl200-l to aminoglycoside resistance. Plasmid DNA 
isolated from carbenicillin and gentamicin resistant Cl200-l 
transformants was subjected to agarose gel electrophoresis 
as described in Figure 10. (A) Strain Cl200-l DNA. (B) 
Strain 2138 DNA. (C) Strain Cl200-l peak III transformant 
selected f~r gentamicin resistance. (D) Strain Cl200-l 
peak III transformant selected for carbenicillin resis-
tance. (E) Strain Cl200-l peak I transformant selected for 
carbenicillin resistance. {F) Strain J53-l{pFL10010) 
transconjugate DNA. 
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on its host bacterium resistance to ampicillin, carbenicillin, genta-
micin, tobramycin, kanamycin, streptomycin, and cephalothin. The 
small plasmid, pFL10020, confers resistance to ampicillin, carbeni-
cillin and cephalothin only upon its host cell. Of the four tested 
no resistance traits have been associated with the plasmid pFL10030. 
7. Host Range Studies 
The prominence of multiple drug resistance among gram-negative 
bacterial isolates from patients at Hines V.A. Hospital has become a 
formidible problem (65). To determine the possible role of pFL10010 
in this scheme, the host range of this plasmid was investigated. 
Standard conjugation experiments were performed using genetically 
characterized members of the Enterobacteriaceae and other gram-
negative genera as recipient strains. If broth matings failed to 
demonstrate transfer of the R plasmid from either strain J53-l 
{pFLlOOlO) or strain 2138 to the recipient strain, the filter method 
was employed as described (see Materials and Methods). Transcon-
jugates were selected on minimal medium containing either gentamicin 
(50 g/ml) or carbenicillin (100 ~g/ml) and the necessary auxotrophic 
requirements. 
The matings and frequencies of conjugation are shown in Table 
VI. With the exception of Proteus mirabilis Pml5, both Cb and Gm 
resistance traits were transferred to the recipients at approximately 
the same frequency. The R plasmid was readily transferred from strain 
J53-l(pFL10010) to ~· coli Cl200-l, Enterobacter cloacae 23355, 
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Table Vt. 
Host Range Studies 
Donor strain a Recipient strain b Transfer frequency 
Cb selection Gm selection 
2138 E. coli J53-1 -2 -2 1.3 X 10_2 1.5 X 10 E. coli Cl200-l 1.3 X 10 1.1 x 1o-l 
P. aerusinosa PA038 NDC 4.5 X 10-7 
P. vulgaris <10-8 <10-8 
J53-l(pFL10010) E. coli Cl200-l -7 -7 3.0 X 10_5 1.8 X 10_5 E. COlacae 23355 
a 
b 
4.4 X 10_7 5.1 X 10_7 s. marcescens 8100 3.1 X 10-8 3.1 X 10-8 
K. pneumonia 27730 9.3 X 10-6 9.3 X 10_6 s. flexneri Sfl 3.2 X 10_5 3.2 X 10_5 P. mirabilis Pm15 2.2 X 10-8 9.3 X 10-8 
s. typhimurium TA1637 2.0 x~O 1.0 X 10 
E. coli CSH-K-12 <10 <lo-8 
P. vulgaris 6380 <lo-8 <1o-s 
P. aeruginosa PA038 <lo-8 <lo-8 
X. tumefaciens B6-806 <10-8 <10-8 
A. tumefaciens 15955 <10-8 <10-8 
All matings using strain 2138 were performed by the filter 
technique. Those matings using strain J53-l(pFL10010) as 
donor were done in broth cultures. (See Materials and Methods 
section). 
Expressed as number of transconjugate colony forming units (CFU) 
per ml divided by number of imput donor CFU per ml. 
c ND -not done. 
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Serratia marcescens 8100, Klebsiella pneumonia 27730, Shigella flexneri 
Sfl, Proteus mirabilis Pml5 and Salmonella typhimurium TA1637 with 
frequencies of conjugation ranging from lo-5 to lo-8. Transfer of 
the R plasmid was not detected in matings between J53-l(pFL10010) and 
!· coli CSH Kl2, Proteus vulgaris 6380, Pseudomonas aeruginosa PA038, 
or Agrobacterium tumefaciens strains B6-806 or 15955. 
Attempts to transfer the R plasmid from strain 2138 could not be 
achieved without the use of membrane filters to concentrate the donor 
and recipient cells. Using the filter method, the R plasmid was sue-
cessfully transferred from strain 2138 to !· coli J53-l, E. coli 
Cl20Q-l, and Pseudomonas aeruginosa PA038. Carbenicillin resistance 
only was transferred to Proteus mirabilis Pml5, and no transfer of 
antibiotic resistance could be demonstrated with the Proteus vulgaris 
6380 recipient. Most significantly, the transfer of the R plasmid to 
!· aeruginosa PA038 expanded the host range of this plasmid beyond the 
Enterobacteriaceae. However, the plasmid was not transferred to the 
strains of Agrobacterium which have been shown to accept other broad 
host rangeR plasmids (96, 108). 
Transconjugates from each mating were examined for their anti-
biotic resistance phenotype using the disk diffusion technique pre-
viously described. A minimum of 10 clones from each mating were tested 
and the results are given in Table VII. As indicated, some of the re-
cipient strains are inherently resistant to certain antibiotics. For 
example, Serratia marcescens 8100 and Klebsiella pneumonia 27730 are 
resistant to ampicillin, !· mirabilis Pml5 is resistant to tetracycline, 
Table VII. 
Resistance patternsa of donor, recipient and transconjugate strains. 
Strainb Antibioticc No. of isolates d 
P. mirabilis 2138 Ap Cb Gm Tm Km Sm Cs Cl Nm Tc 1 !· coli J53-l(pFL10010)e * Ap Cb Gm Tm Km Sm Cl Rm 1 
E. coli Cl200-l Rm 1 
Cl200-l(pFL10010) Ap Cb Gm Tm Km Sm Cl Rm 10/10 
P. mirabilis Pm15 ND Tc Rm 10/10 
- Pml5(p-FL10010) Ap Cb Gm Tm Km Sm NDf 15/15 Tc Rm 
* Ap Km Sm Cs Cl Tc 10/10 ~· aeruginosa PA038 
PA038(pFL10010) Ap Cb Gm Tm Km Sm Cs Cl Tc 12/12 
E. cloacae 23355 10/10 
23355(pFL10010) ApCbGmTmKmSm Cl 10/10 
s. marcescens 8100 Ap Cl 10/10 
8100(pFL10010) Ap Cb Gm Tm Km Sm Cl 10/10 
~· typhimurium TA1637 10/10 
TA1637(pFL10010) Ap Cb Gm Tm Km Sm Cl 10/10 
!• pneumonia 27730 ND 5/5 
27730(pFL10010) ND Cb Gm Tm Km Sm Cl 10/10 
S. flexneri Sfl 5/5 
Sfl{pFLlOOlO) Ap Cb Gm Tm Km Sm Cl 10/10 
a All strains were tested for resistance to Ap, Cb, Gm, Tm, Km, Sm, Cs, Cl, Nm, Tc and Rm by the disk 
diffusion method {69). 
b Transconjugate strains resulting from matings using strain 2138 as donor are indicted by*. All 
other transconjugate strains resulted from matings with strain J53-l{pFL10010). 
c Abbreviations as described in Table III. 
d Number of clones having this phenotype per total number of clones tested. 
e E. coli J53-l{pFL10010) was formerly designated as E. coli J53-l(Pl). 
f ND - not done. - ----
00 
........ 
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and f. aeruginosa PA038 is resistant to ampicillin, kanamycin, strepto-
mycin, colistin, cephalothin and tetracycline. As seen in the 
original mating between strains 2138 and J53-l, no transfer of re-
sistance to either neomycin or tetracycline was detected. A resistance 
phenotype of Ap, Cb, Gm, Tm, Km, Sm, and Cl was transferred ~ bloc to 
the transconjugate strains. Although the recipient strain!· aeruginosa 
PA038 was resistant to five of the antibiotics, the transconjugate 
clones showed additional resistance to Cb, Gm, and Tm indicating that 
transfer of pFLlOOlO had occurred, 
In the mating between strain 2138 and !· mirabilis PmlS resis-
tance to the beta-lactam antibiotics only was detectable. However, 
the transconjugates resulting from the mating of strains J53-l 
(pFLlOOlO) and PmlS demonstrated resistance to the aminoglycoside 
antibiotics as well (Table VII). It is possible in matings with 
strain 2138 that the smaller plasmid pFLl0020 could have been mobi-
lized by the transfer of pFLlOOlO, but this would not be detectable by 
phenotype. 
8. Plasmid Stability 
It was noted during routine passage of stock cultures that some 
clones not maintained on medium containing gentamicin lost their re-
sistance to that antibiotic. Plasmid stability in several transcon-
jugates was checked by passing clones daily onto fresh NA plates and 
testing at two week intervals for Gm and Cb resistance. One hundred 
clones of each strain were tested, and the results are shown in Table 
VIII. From this data it is evident that the stability of the plasmid 
Table VIII 
a Stability of plasmids in transconjugate strains. 
Subclones showing growth (%) 
b Strain Test •edium:c Na Cb 
No. P.assages: 14 28 42 14 28 42 14 
P. mirabilis 2138 100 100 100 100 100 100 100 
P. mirabilis Pml5{pFL10010) 100 100 100 100 100 100 52 !. coli J53-l{pFL100lO)* * 100 100 100 100 100 100 57 
!· aeruginosa PA038{pFL10010) 100 100 100 95 80 40 97 
!· coli Cl200-l(pFL10010) 100 100 100 100 100 100 100 
!· flexneri Sfl(pFLlOOlO) 100 100 100 100 100 100 100 
!• marcescens 8100(pFL10010) 100 100 100 26 20 0 0 
!· pneumonia 27730(pFL10010) 100 100 100 100 100 100 66 
E. cloacae 23355(pFL10010) 100 100 100 100 100 100 100 
!• t~~himurium TA1637(pFL10010) 100 100· 100 100 100 100 100 
a All strains passed on nutrient agar. 
>.· 
Gm 
28 
100 
25 
6 
0 
100 
100 
0 
50 
100 
100 
b Strains derived from matings with strain 2138 are indicated by *· All other strains derived 
from matings with J53-l(pFL10010). 
c NA- nutrient agar, Cb -nutrient agar containing carbenicillin (100 ~g/ml), Gm- nutrient 
agar containing gentamicin (50 ~g/ml). 
42 
100 
0 
0 
0 
100 
'100 
0 
50 
100 
100 
00 
1..0 
90 
is a function of the strain in which it is harbored as well as the 
nature of the plasmid itself. Gentamicin resistance, carried only on 
the l~rge plasmid, pFLlOOlO, was unstable in five transconjugate 
strains: ~· mirabilis Pml5 {pFLlOOlO), ~· coli J53-l(pFL10010), P. 
aeruginosa PA038{pFL10010), ~· marcescens 8100{pFL10010) and K. 
pneumonia 27730(pFL10010). Carbenicillin resistance which is carried 
on both plasmids, pFL10010 and pFL10020, was lost in only two strains: 
!· aeruginosa PA038(pFL10010) and~· marcescens 8100(pFL10010). In 
both cases loss of Cb resistance was concomitant with the loss of Gm 
resistance. Disk diffusion testing further showed that those clones 
which had lost Gm resistance also lost resistance to the other amino-
glycoside antibiotics. 
CHAPTER IV 
DISCUSSION 
Infections of the urinary tract with strains of Proteus mirabilis 
are common and second only to Escherichia coli infections in the fre-
quency with which they occur (97). Due to their special predilection 
for the upper urinary tract, Proteus infections cause much greater 
kidney damage than E. £2!! infections which are usually limited to the 
bladder. Proteus mirabilis is now recognized as a frequent nosocomial 
pathogen and has been implicated in several nosocomial ou~breaks of in-
fection (9). The increasing number of Proteus clinical isolates re-
sistant to aminoglycoside therapy has become a medical problem (87). 
Yoshikawa~~· (116) have undertaken an extensive study of the 
antimicrobial susceptibility pattern of Proteus isolates, and have 
shown an increasing occurrence of resistant Proteus strains. Due to 
the cross reactivity of aminoglycoside inactivating enzymes (78, see 
Introduction), the efficacy of treatment with those antibiotics has 
been greatly reduced. Since there are only two known enzymes that in-
activate Amikacin, it is now considered the drug of choice for Proteus 
infections. However, the effectiveness of Amikacin may be decreasing 
with the increased number of resistant isolates (116). 
In this study a Proteus mirabilis clinical isolate (strain 2138) 
was shown to be multiply resistant to Ap, Cb, Gm, Km, Nm, Sm, Tm, Cs, 
Cl and Tc (Table III). Analysis of the MBC of these drugs reveals high 
levels of resistance, well in excess of obtainable patient serum levels 
for each antibiotic. Such high levels of antibiotic resistance, as 
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seen in strain 2138, are usually indicative of R plasmids which con-
situtively synthesize antibiotic inactivating enzymes (78). 
The genetic evidence from matings with E. coli clearly show that 
the resistance phenotype is due, in part, toR plasmids (Table III). 
Resistance to tetracycline was not transferrable and probably reflects 
the inherent chromosomal resistance to this antibiotic which is 
characteristic of the species (30). It is unlikely that resistance to 
neomycin and tetracycline exist on the large plasmid but are not pheno-
typically expressed. Were this the case expression of antibiotic re-
sistance to those drugs should have been seen in at least some of the 
transconjugate strains. Resistance to tetracycline and neomycin was 
not detected in any of the transconjugants using the J53-l(pFL10010) 
donor. Given the cross-reactivity of aminoglycoside inactivating en-
zymes, it is interesting to note that neomycin resistance was not 
transferred along with resistance to five other antibiotics. 
There must be several antibiotic inactivation enzymes in strain 
2138, including a beta-lactamase and at least two aminoglycoside in-
activating enzymes. The most common beta-lactamases associated with 
plasmids and transposons of gram-negative origin are the TEM-like 
enzymes. Unlike the 0 type, the TEM beta-lactamases have a broader 
general activity on penicillins and cephalosporins (39, see Intro-
duction), such as that observed in strain 2138. A single aminoglyco-
side inactivating enzyme could account for Gm-Tm-Km inactivation (see 
Introduction). Analysis of the substrates of the inactivation enzymes 
reveals that more than one enzyme is known to effect Gm-Tm-Km in-
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activation without inactivating Nm. No enzyme is known to inactivate 
any of these three aminoglycosides exclusively, although strain 2138 
may carry two or three enzymes which inactivate different combinations 
of enzymes. Since streptomycin inactivating enzymes are specific and 
do not cross react with other aminoglycosides, strain 2138 must also 
contain a streptomycin inactivating enzyme. The mechanism of resis-
tance to colistin (Polymixin E) is unknown but it appears not to be 
plasmid coded. Several gram-negative species, including Proteus, are 
known to be insensitive to this drug, and the resistance is thought to 
be chromosomally mediated (30). 
Physical-chemical evidence of the existence of extrachromosomal 
DNA in strain 2138 and its transconjugate strain J53-l(pFL10010), came 
from isolation of ~lasmid DNA in CsCl-EtBr density gradients (Figure 1). 
Initial isolations using the Helinski lysis procedure led to the de-
tection of two plasmid species in strain 2138, but only one in strain 
J53-l(pFL10010). Contour length measurements of electronmicrographs 
showed the molecular mass of the Prot~us plasmids to be approximately 
5 and 27 megadaltons, whereas the plasmid isolated from the .!· ..££.!.!. 
transconjugate was 90 megadaltons. Early speculations that the 90 Mdal 
plasmid might be dissociated in the Proteus species, or that the trans-
conjugate plasmid was a trimer of the 27 Mdal plasmid were disproven. 
The two plasmids isolated from strain 2138 failed to transform .!· coli 
Cl200-l to aminoglycoside resistance. However, resistance to the 
penicillins was transferred by the smaller plasmid. 
Analysis of neutral and alkaline sucrose gradients of strain 2138 
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plasmid DNA isolated by the Helinski method led to the conclusion that 
a third, larger plasmid existed in that species. The Currier plasmid 
isolation procedure was employed for its ability to isolate large plas-
mids without breakage (15). Through use of this technique, a 90 mega-
dalton plasmid was isolated from strain 2138. Comparison of contour 
length measurements and migrations in agarose gels revealed that the 
large plasmid found in strain 2138 was the same size as the plasmid 
isolated from the transconjugate strain J53-l(pFL10010). 
The difficulty in isolating the 90 Mdal plasmid from strain 2138 
using the Helinski partial lysate technique was most probably due to 
its size and to the susceptibility of Proteus to the detergents used to 
lyse the cells. Although the plasmid was recovered from strain J53-l 
(pFLlOOlO) using this method, the yield was poor. The Helinski method 
is based on a partial lysis of the bacterial cell wall which allows the 
leakage of small plasmid molecules while retaining the larger chromo-
some. The Proteus cells were not highly susceptible to the lysis which 
explains why only the small molecules were recovered. The E. coli cells 
were extremely sensitive to the lysis which often went to completion 
allowing the large plasmid, along with the chromosome, to leak out. 
The alkaline sucrose gradients showed that some 90 Mdal plasmid DNA was 
present in the Proteus lysates but its detection was initially masked 
by the high yields of the smaller plasmids. The Currier method of 
plasmid isolation involves a total lysis of the cells with subsequent 
separation of the chromosome from plasmid DNA. This method was de-
signed for isolation of large plasmids (in excess of 60 Mdal) and 
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proved to be effective in this study. Yields of pFL10010 plasmid DNA 
from both strains 2138 and J53-l(pFL10010) were significantly increased 
using this method. 
Conclusive evidence that the 90 Mdal pFLlOOlO plasmid was the R 
plasmid responsible for aminoglycoside resistance comes from the trans-
formation of ~· ££!! Cl200-l using highly purified and size-fraction-
ated plasmid DNA isolated from strain 2138. Although the 5 Mdal plasmid 
pFL10020 was shown to transform strain Cl200-l to penicillin resistance, 
only the pFL10010 appeared capable of transforming strain Cl20Q-l to 
aminoglycoside resistance (Table V). Cells transformed with pFLlOOlO 
DNA were found to contain only this plasmid (Figure 1). 
The host range studies (Table VI) further revealed that the 
pFL10010 plasmid could be transferred in vitro to several strains of 
the Enterobacteriaceae and also to the non-Enterobacteriaceae species 
Pseudomonas aeruginosa PA038. However, the frequency of transfer of 
the plasmid was low, and could only be achieved through use of the 
filter mating technique. Concentration of donor and recipient cells 
by vacuum aspiration onto millipore filters increases eell to cell 
contact thus enhancing the probability of plasmid transfer. Employ-
ment of this technique did not prove successful in all cases. No de-
tectable plasmid transfer was seen between strains 2138 and Proteus 
vulgaris 6380, and only carbenicillin resistance was transferred to 
Proteus mirabilis Pm15. In general, Proteus species are considered 
poor donors and recipients of R plasmids (24) and several R plasmids 
are known to undergo dissociation in this species (see Introduction)". 
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However, one would expect an intragenic transfer of R plasmids to 
succeed. The fact that transfer to ~· vulgaris 6380 using strain 
J53-l(pFL10010) as donor also failed is probably a reflection of the 
inherent properties of that strain and is consistant with other experi-
ments involving this strain (24). It is interesting that~· miribilis 
Pml5 received only the carbenicillin resistance trait when mated with 
strai~ 2138, yet received both Cb and aminoglycoside resistance traits 
when mated with J53-l(pFL10010). In plasmid stability experiments 
gentamicin-resistant clones of strain PmlS(pFLlOOlO} not maintained on 
em-containing medium lost their resistance to Gm while retaining Cb 
resistance (Table VIII). It appears that the R plasmid is not stably 
maintained by this-strain, and that the Cb-resistance trait can main-
tain independent existence in this strain. Since the pFL10020 plasmid 
could not have been recieved in matings with J53-l(pFL10010), it seems 
likely that the Cb-resistance determinant on the pFLlOOlO plasmid has 
transpositional activity, and has integrated into the chromosome or 
some indigenous plasmid of strain PmlS{pFLlOOlO). 
In addition to~· vulgaris 7380, other strains failed to acquire 
the R plasmid in broth matings with J53-l(pFL10010). These include 
matings with the non-related species of Agrobacterium tumefaciens and 
f. aeruginosa PA038. It is interesting that the intragenic mating 
between J53-l(pFL10010), a Kl2 derivative, and E. coli CSH-Kl2 also 
failed. Successful transfer of the R plasmid was achieved from strain 
J53-l(pFL10010) to E. coli Cl200-l, but only at low frequency of trans-
fer (10~7). It is possible that t2ansfer to strain CSH-K-12 may have 
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occurred, but was below the detectable limits of the experiment (10-8), 
and would have been enhanced through use of the filter mating technique. 
It is possible that phage . I. could have been liberated from J53-l 
(pFLlOOlO) donor and killed the CSH-K12 recipient which does not con-
tain the phage. However, were this the case, one would have expected 
strain CU00-1, which also lacks the phage, to be killed. It was 
later found that the stock cultures of strain CSH-K-12 may have been 
contaminated. 
The promiscuity of the R plasmid pFLlOOlO is shown by its ability 
to transfer to the non-Enterobacteriaceae species Pseudomonas aeruginosa. 
Since strain PA038 is intrinsically ampicillin resistant, gentamicin 
selection alone was used for the mating. The disk diffusion tests did 
show that the transconjugate strain PA038(pFL10010} did acquire other 
resistance traits encoded by pFLlOOlO (Table VII). Broth matings 
between strain J53-l(pFL10010) and PA038 did not yield transconjugates. 
However, successful mating was achieved between strains 2138 and PA038 
when the filter disk technique was employed. This indicates that 
Pseudomonas is a poor recipient and transferability is only detected 
when enhanced by the filter technique. Of clinical significance be-
yond the broad host range of the R plasmid, is its ability to transfer 
at high frequencies to the pathogenic species of Shigella, Salmonella 
and Klebsiella. A multiply resistant plasmid with these capabilities 
could present a formidible medical challenge. 
As previously mentioned, the R plasmid was not maintained in all 
transconjugate clones. As in the case of P. mirabilis Pml5(pFL10010), 
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the strains ~· coli J53-l(pFL10010) and ~· pneumonia 27730(pFL10010) 
lost Gm resistance while retaining Cb resistance. Resistance to both 
Gm and Cb was lost in clones of ~· aeruginosa PA038(pFL10010) and i· 
marcescens 8leo(pFL10010). It is possible that in matings with 
strain 2138 the smaller plasmid pFL10020 could be mobilized during 
transfer of pFLlOOlO. The transconjugate strain having pFL10020 would 
continue to be Cb resistant even if it lost the larger plasmid. Since 
strain 27730(pFL10010) is the result of a mating using J53-l(pFL10010) 
as donor, retention of the Cb resistance trait cannot be explained by 
the presence of the plasmid pFL10020 in the transconjugate strain. 
It appears that the R plasmid pFLlOOlO contains a Tnt-like 
transposon capable of either independent existence of chromosomal 
integration. The size of the Proteus plasmid pFL10020 is consistant 
with known Tn1-like transposons (25) which raises the possibility that 
this small plasmid may be a dissociated r-determinant derived from the 
pFLlOOlO plasmid. 
In a hospital environment where the increased use of prophylactic 
antibiotics provides a selective pressure, the evolution of multiply-
resistant R plasmids is encouraged. Given the promiscuity of the 
plasmid pFL10010, one might envision its evolution to multiple re-
sistance by acquiring resistance traits singly as it was transferred 
among various species of bacteria. The possibility of transpositional 
activity of pFL10020 makes this suggestion credible. The fact that the 
R plasmid did not transfer to ~· vulgaris 6380 and only to ~· mirabilis 
Pml5 at low frequency suggests that Proteus may not be the original 
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host of the R plasmid, and was just the most recent of many hosts in 
its evolution. 
CHAPTER V. 
LITERATURE CITED 
1. Ak.iba, T., K. Koyana, Y. Tshiki, S. Kimura and T. Fukuahiaa. 
1960. On the mechanisms of the development of multiple drua 
resistant clones of Shigella. Japan. J. Microbial. !:219-230~ 
2. Anderson, E. S. 1968. The ecology of transferable drug re8is- · 
tance in the Enterobacteria. Ann. Rev. Microbial •. ~~lll-180. 
3. Anderson, E. S. and N. J. Lewis. 1965. Characterizati •. oC:a 
transfer factor associated with drug resistance in Sal~lla 
tyPhimurium. Nature 208:843-849. 
4. Anderson, E. s. and E. Natkin. 1972. Transduction of .~~lance 
determinants and R factors of the Delta transfer systeiiSlty 
Phage Plkc. Molec. Gen. Genet. 114:261-265. 
5. Barth, P. T., N. Datta, R. W. Hedges and N. J. Grinter. 1976. 
Transposition of a DNA sequence encoding trimethoprin and 
· streptomycin resistances from R483 to other replicons. J. 
Bac teriol. 125:800-810. 
6. Benveniste, R. and J. Davies. 1973. Mechanisms of antibiotic 
resistance in bacteria. Ann. Rev. Biochem. 42:471-506. 
7. Bodey, G. P. and V. Rodriquez. 1979. 
infections on the compromised host. 
Hospital and associated 
Marcel Dekker, Inc. , N. Y; 
8. Bradley, S. G. and L. W. Enquist. 197 4. Microbial nucleic acids, 
p. 47-100. InS. G. Bradley and L. W. Enquist (ed.), MOlecular 
microbiology. John Wiley and Sons, Inc., N. Y. 
9. Chow, A. B., P. R. Taylor, T. T. Yoshikawa and L. B. Guze. · 1979. 
A nosocomial outbreak of infections due to multiply resistaat 
Proteus mirabilis: role of intestinal colonization as a major 
reservoir. J. Infect. Dis. 139:621-627. 
10. Cohen, s. N. and D. J. Kopecko. 1967. Structural evolutioa of 
bacterial plasmids: role of translocating genetic elements and 
DNA sequence insertions. Proc. Natl. Acad. Sci. U.S.A. 1!= 
2031-2036. 
11. Cohen, S. N. and c. A. Miller. 1970. Non-chromosomal antibiotic 
resistance in bacteria, II; molecular nature of R factors 
isolated from Proteus mirabilis and Escherichia coli. J. Mo1. 
Biol. 50:671-687. 
100 
101 
12, Cohen, S. N. and C, N. Miller, 1970. Non-chromosomal antibiotic 
resistance in bacteria, III; Isolation of discrete transfer 
unit of the R-factor Rl. Proc. Natl. Acad. Sci. U.S.A. 67: 
510-516. 
13. Crosa, J. H., D. J. Brenner and s. Falkow. 1973. Use of a 
single-stranded specific nuclease for analysis of bacterial and 
plasmid DNA homo- and heteroduplexes. J. Bacterial. 115: 
904-911. 
14. Cr9sa, J. H., L. K. Luttropp and s. Falkow. 1976. Mode of 
replication of the conjugative R plasmid RSF1040 in Escherichia 
~· J. Bacterial. 126:454-466. 
15. Currier, T. C. and E. W. Nester. 1976. Isolation of covalently 
closed circular DNA of high molec.ular weight from bacteria. 
Analyt. Bioch, 76:431-441. 
16. Datta, N. 1974. Epidemiology and classification of plasmids, 
p. 9-14. In Microbiology 1974. American Society for 
Microbiology, Washington. 
17. Datta, N. and P. Kontamachalou. 1965. Penicillin synthesis 
controlled by R. factors in Enterobacteriaceae. Nature 
(London) 208:239-251. 
18. Davies, J., M. Brezezinska and R. Benveniste. 1971. R factors: 
biochemical mechanisms of resistance to aminoglycoside anti-
biotics. Ann. N.Y. Acad. Sci. 182:226-233. 
19. DeLey, J. 1970. Reexamination of the association between 
melting point, bouyant density and a chemical base composition 
of deoxyribonucleic acid. J. Bacterial. 101:738-754. 
20. Demerec, M. 1945. Production of Staphylococcus strains re-
sistant to various concentrations of penicillin. Proc. Natl. 
Acad. Sci. U.S.A. 31:16-23 
21. Ehrlich, P. and S. Rata. 1910. Die experimentelle chemotherapie. 
InT. H. Grainger, Jr. (ed.), The history of bacteriology. 
The Ronald Press Company, N.Y. 
22. Falkow, S. 1975. Infectious multiple drug resistance. Pion 
Ltd., London. 
23. Falkow, s., R. v. Citarella, J. A. Wehlhieter and T. Watanabe. 
1966. The molecular nature of R factors. J. Mol. Biol. 
g:102-116. 
24. Ealkow, S. and P. Guerry. 1974. ·Polynucleotide sequence 
relationships among plasmids of the I compatibility complex. 
J. Gen. Microbial. 85:65-76. 
102 
25. Falkow, S., D. K. Haapala and R. P. Silver. 1979. Relationships 
between extrachromosomal elements, p. 136-158. In G. E. W. 
Wolstenholme and M. O'Connor (ed.), Bacterial episomes and 
plasmids. J. A. Churchil, Ltd., London. 
26. Flamm, W. G., H. E. Bond and H. E. Burr. 1966. Density gradient 
centrifugation of deoxyribonucleic acid in a fixed angle rotor: 
a higher order of resolution. Biochim. Biophys. ACTA 129: 
310-319. 
27. Flemming, A. 1946. Penicillin: it's practical application. 
The Blakeston Company, Philadelphia. 
28. Foster, T. J., T. G. B. Howe and K. M. V. Richmond. 1975. 
29. 
Translocation of the tetracycline R determinant from Rl00-1 
to the Escherichia coli chromosome. J. Bacterial. 124: 
1153-1158. 
Franklin, T. J. and J. M. Cook. 1971. 
in the tetracycline resistance marker. 
R factor with a mutation 
Nature 229:273-275. 
30. Goodman, L. s., and A. Gilman (eds.). 1975. The Pharmacological 
Basis of Therapeutics. Macmillan Publishing Co., Inc., N.Y. 
31. Grindley, N. D. F., G. 0. Humphreys and S. E. Anderson. 1973. 
Molecular studies of R factor compatibility groups. J. 
Bacterial. 115:387-398. 
32. Groschel, D. 1979. Hospital-associated infections in the 
general hospital population and measures of control. Marcel 
Dekker, Inc., N.Y. 
33. Guerry, P. and R. P. Colwell. 1977. Isolation of cryptic 
plasmid deoxyribonucleic acid from Kanagawa-positive strains 
of Vibrio parahaemolyticus. Infection and Immunity 16: 
328-334. 
34. Guerry, P., S. Falkow and N. Datta. 1974. R62, a naturally 
occurring hybrid R plasmid. J. Bacterial. 119:144-151. 
35. Guerry, P., D. J. LeBlanc and s. Falkow. 1973. General method 
for the isolation of plasmid DNA. J. Bacteriol. ~: 
1064-1066. 
36. Haapala, D. K. and S. Falkow. 1971. Physical studies of the 
drug-resistance transfer factor in Proteus mirabilis. 
J. Bacterial. 106:294-295. 
103 
37. Harwick, H. J., P. Weiss, and F. R. Fekety, Jr. 1968. Appli-
cation of microtitration techniques to bacteriostatic and 
bactericidal antibiotic susceptibility testing. J. Lab. Clin. 
Med. 72:511-516. 
38. Hashimoto, H. and R. H. Rownd. 1975. Transition of the R factor 
NRl in Proteus mirabilis: level of drug resistance of non-
transitioned and transitioned cells. J. Bacterial. 123: 
56-68. 
39. Hedges, R. W., N. Datta, P. Kontomichalou and J. T. Smith. 1974. 
Molecular specificities of R factor determined Beta-lactamases: 
correlation with plasmid compatibility. J. Bacterial. 117: 
56-62. -
40. Hedges, R. W. and R. Jacobs. 1974. Transposition of Amp 
replicon from RP4 to other replicons. Molec. Gen. Genet. 
132:31-40. 
41. Heffron, F., P. Bedinger, J. J. Champoux and S. Falkow. 1977. 
Deletions affecting the transposition of an antibiotic 
resistance gene. Proc. Nat~. Acad. Sci. U.S.A. 74:702-706. 
42. Helinski, D. R. 1976. Plasmids. Proc. Natl. Acad. Sci. U.S.A. 
35:2024-2025. 
43. Helinski, D. R. and D. B. Clewell. 1971. Circular DNA. Ann. 
Rev. Bioch. 40:899-942. 
44. Hu, S., E. Chtsuko, N. Davidson and H. Saedler. 1975. Electron 
microscope heteroduplex studies of sequence relations among 
bacterial plasmids: identification and mapping of the in-
sertion sequences IS! and IS2 in F and R plasmids. J. 
Bacterial. 122:764-775. 
45. Hugo, W. B. and A. D. Russell. 1977. Pharmaceutical micro-
biology. Blackwell Scientific Publications, Oxford. 
46. Humphreys, G. D., G. A. Willshaw and E. S. Anderson. 1975. A 
simple method for the preparation of large quantities of pure 
plasmid DNA. Biochim. Biophys. ACTA 383:457-463. 
47. Ingram, L. C. 1973. Deoxyribonucleic acid-deoxyribonucleic acid 
hybridization of R-factors. J. Bacterial. 115:1130-1134. 
48. !none, M., T. Okubo, H. Oshima and S. Mitsuhashi. 1975. Staphy-
lococcal plasmids carrying tetracycline and chloramphenicol 
resistance, P. 153-164. Ins. Mitsuhashi and J. Hashimoto (ed.), 
Microbial drug resistance. University Park Press, Baltimore. 
104 
49. Jacob, A. E, and S. J. Hobbs. 197.4. Conjugal transfer of 
plasmid-borne multiple antibiotic resistance in Streptococcus 
faecalis-var. ZY!ogenes. J. Bacteriol. 117:360-372. 
50. Kasamatsu, H. and R. Rownd. 1970. Replication of R factors in 
Proteus mirabilis: replication under relaxed control. J. 
Mol. Biol. 51:473-489. 
51. Kleinschmidt, A. K., D. Lang, D. Jocherts and R. K. Zahn. 1963. 
Preparation and length measurements of the total DNA content 
of T-2 bacteriophages. (In German) Biochim. Biophys. ACTA 
61:857-864. 
52. Knothe, K., M. Keltner and V. Krcmery. 1977. R plasmids in 
Providencia and Proteus strains from Frankfurt University 
Hospital. InS. Mitsuhashi, L. Rosival and V. Krcmery (ed.). 
Plasmids: medical and theoretical aspects. Springer-Verlag, 
Berlin. 
53. Kontamichalou, P., M. Mitani and R. C. Clowes. 1970. Circular 
R factor molecules controlling penicillinase synthesis, 
replication in Escherichia coli under either relaxed or 
stringent control. J. Bacteriol. 104:34-44. 
54. Kontomichalou, P., E. Papachriston and G. Levis. 1974. TEM-like 
penicillinases in contemporary plasmids of Enterobacteriaceae 
and Pseudomonas. Comparison with Beta-lactamases of preanti-
biotic Klebsiella, p. 27-33. In s. Mitsuhashi, L. Rosival 
and V. Krcmery (ed.), Drug inactivation enzymes and antibiotic 
resistance. Springer-Verlag, Berlin. 
55. Kopecko, D. J., J. Brevet and S. N. Cohen. 1976. Involvement of 
multiple translocating deoxyribonucleic acid segments and 
recombinational hotspots in the structural evolution of 
bacterial plasmids. J. Mol. Biol. 108:333-360. 
56. Krcmery, v., L. Rosival and T. Watanabe (ed.). 1972. Bacterial 
plasmids and antibiotic resistance. Springer-Verlag, Berlin. 
57. Kretschmer, P. J. and S. N. Cohen. 1977. Selected translocation 
of plasmid genes: frequency and regional specificity of 
translocation of the Tn3 element. J. Bacteriol. ~:888-900. 
58. Kuperstoch, Y. M. and D. R. Helinski. 1973. A concatenated DNA 
molecule as an intermediate in the replication of the resis-
tance transfer factor R6K in Escherichia coli. Biochim. 
Biophys. Res. Commun. 54:1451-1460. 
lOS 
. 
59. Lang, D. 1970. Molecular weigb..ts of coliphages and eoliphage 
DNA Ili. Contour lengths and ~lecular weight of DNA from 
oacteriophages T4, T5, and T7 and from Bovine Papilloma virus. 
J. Mol. Biol. 54:557-565. .· .. 
60. Leder berg, E. M. and S. N. Cohen. • 19 7 4. Transformati~ of 
Salmonella typhimurium by plas~d deoxyribonucleic acid. 
J. Bacteriol. 119:1072-1074. 
61. Lederberg, J. and E. L. Tatum. 1946. Novel genotypes in mixed 
cultures of biochemical mutants of bacteria. Cold Spring 
Harbor Symp. Quant. Biol. 11: 113-114. 
62. Levin, R. A., s. K. Farrand, M. P. Gordon and E. w. Nester. 1976. 
Conjugation in Agrobacterium t umefaciens in the absence of 
plant tissue. J. Bacterial. ~:1331-1336. 
63. Lewin, B. 1977. Gene expressie>n. John Wiley and Sons, N. Y. 
64. Luria, s. E. and M. Delbruck. L943. Mutations of bacteria from 
virus sensitivity to virus resistance. Genetics 1!:491•511. 
65. Maliwan, N., H. G. Grieble and T'. J. Bird. 1975. Hospital 
Pseudomonas aeruginosa: surveillance of resistance to 
gentamicin and transfer of amLnoglycoside R factor. Anti-
microb. Agents Chemother. 15: 93-100. 
66. Mandel, M., L. Igambi, J. Bergen.dahl, M.S. Dodson ancl E. 
Schultgen. 1970. Correlation. of melting temperature and 
cesium chloride bouyant density of bacterial deoxyribonucleic 
acid. J. Bacterial. 101:333-338. 
67. Marmur, J. 1961. Procedure for isolation of deoxyribonucleic 
acids from microorganisms. J. Mol. Biol. 3: 208-218. 
68. Marvin, D. A. and B. Hohn. 1969. Filamentous bacterial viruses. 
Bacterial. Rev. 33:172-204. 
69. Matsen, J. M. and A. L. Barry. 1974. Susceptibility testing: 
diffusion test procedures, p. 418•427. In E. H. Lennett, 
E. H. Spaulding and J. P. TruSLnt (ed.), Manual of clinical 
microbiology. American Society for Microbiology, Washington. 
70. Meyer, R. 1974. Alternate forn1s of the resistance factor Rl in 
Proteus mirabilis. J. BacterLol. 118:1010-1019. 
71. Meyers, J. A., D. Sanchez, L. P. Elwell and s. Falkow. 1976. 
Simple agarose gel electrophoretic method for the identifi-
cation and characterization of plasmid deoxyribonucleic 
acid. J. Bacterial. 127:1529-1537. 
72. 
106 
Meynell, E. and N. Datta. 1967. Mutant drug resistant factors 
of high transmissibility. Nature 214:885-887. 
73. Milliken, C. E. and R. c. Clowes. 1973. Molecular structure of 
an R factor, its component drug resistance determinants and 
transfer factor. J. Bacteriol. 115:1026-1033. 
74. Mitsu~ashi, S. 1969. Review: the R factors. J. Infect. 
Disease 119:89-100. 
75. Mitsuhashi, S, 1977, R factor-drug resistant plasmids. 
University Park Press, Baltimore. 
76. Mitsuhashi, s. 1977. Epidemiology of bacterial drug resistance. 
77. 
InS. Mitsuhashi (ed.), R factor-drug resistance plasmid. 
University Park Press, Baltimore. 
Mitsuhashi, s., L. Rosival and v. Kremery (ed.). 
inactivating enzymes and antibiotic resistance. 
Verlag, Berlin. 
1975. Drug 
Srpinger-
78. Mitsuhashi, S., S. Yamagishi, T. Sawai," and H. Kawabe. 1977. 
Biochemical mechanisms of plasmid-mediated resistance, p. 
195-251. Ins. Mitsuhashi (ed.), R factor: drug resistance 
plasmid. University Park Press, Baltimore. 
79. Morris, C. F. and R. Rownd. 
R12 in Proteus mirabilis. 
1974. Transition of the R-factor 
J. Bacteriol. 118:867-879. 
80. Morrison, T. B. and H. M. Malamy. 1970. Comparison of F factors 
and R factors: existence of independent regulation groups 
in F factors. J. Bacteriol. 103:81-88. 
81. Nakaya, R. and R. Rownd. 1971. Transduction of R factors by 
a Proteus mirabilis bacteriophage. J. Bacteriol. 106:773-783. 
82. Novick, R. P. 1969. Extrachromosomal inheritance in bacteria. 
Bacteriol. Rev. 33:210-263. 
83. Novick, R. P., R. c. Clowes, s. N. Cohen, R. Curtiss III, N. 
Datta and S. Falkow. 1976. Uniform nomenclature for bacterial 
plasmids: a proposal. Bacteriol. Rev. 40:168-189. 
84. Novick, R. P. and F. c. Hoppensteadt. 1978. On plasmid in-
compatibility. Plasmid 1:421-434. 
85, Ochiai, K., K. Yamanaka, K, Kimura and C. Sawada. 1959. 
Nihon !ji Shimpo No. 1861: 31-46. (In Japanese). 
107 
86, Olexy, V, ~·~ T, J, Bird, H. G. Grieble and s. K. Farrand. 1979. 
Hospital isolates of Serratia marcescens transferring ampicillin 
carbenicillin and gentamicin resistance to other gram-negative 
bacteria including Pseudomonas aeruginosa. Antimicrob. Agents 
Chemother. 15:93-100, 
87. Parker, M. T. 1978. Hospital acquired infections: guidelines 
to laboratory methods. World Health Organization, Copenhagen. 
88. Pato, M. L. and G. L. Brown. 1963. Arch. Biochem Biophys 
.±Q2.: 443-448 • 
89. Perlman, D. and R. H, Rownd. 1975. Transition of R factor NRl 
in Proteus mirabilis: molecular structure and replication of 
NRl deoxyribonucleic acid. J. Bacterial. 123:1013-1034. 
90. Ptasbne, K, and S. N. Cohen. 1975. Occurrence of insertion 
sequence (IS) regions on plasmid deoxyribonucleic acid as 
direct and inverted nucleotide sequence duplications. J. Bac-
terial. 122:776-781. 
91. Radloff, R., W. Bauer and J. Vinograd. 1967. A dye-bouyant-
density method for the detection and isolation of covalently 
closed circular DNA: the covalently closed DNA in HeLa 
cells. Proc. Natl. Acad. Sci. U.S.A. 57:1514-1519. 
92. Rownd, R. H., N. Goto, E. R. Appelbaum and D. Perlman. 1975. 
Dissociation and transition of R plasmids in Proteus mirabilis 
p. 3-26. InS. Mitsuhashi and H. Hashimoto (eds.), Microbial 
drug resistance. University Park Press, Baltimore. 
93. Rownd, R. and S. Mickel. 1971. Dissociation and reassociation 
of RTF and r-determinants of the R factor NRl in Proteus 
mirabilis. Nature N. Biol. 23440-43. 
94. Rownd, R. and D. D. Womble. 1977. Properties of the relaxation 
complex of supercoiled deoxyribonucleic,-acid and protein of 
R plasmid NRl in Escherichia coli. J. Bacterial. 131:145-152. 
95. Rownd, R. and D. D. Womble. 
replication of R factors. 
drug resistance plasmids. 
1977. Molecular nature and 
Ins. Mitsuhashi (ed.), R factor 
University Park Press, Baltimore. 
96. Schell, J. and M. VariMontagu. 1977. The Ti-plasmid of 
Agrobacterium tumefaciens, a natural vector for the intro-
duction of nif genes in plants, p. 159-179. In A. Hollaender 
(ed.), Conference on genetic engineering for nitrogen 
fixation. Brookhaven National Laboratory, Upton, N. Y. 
108 
97, Se~ior, B. W, 1979, !he special affi~ity of particular types 
of Proteus mirabilis for the uri~ary tract. J. Med. Microbial. 
12:1-8. 
98. Sharp, P. A., s. N. Cohen and N. Davidson. 1973. Electron 
microscope heteroduplex studies of sequence relations among 
plasmids of Escherichia coliii: structure of drug resistance 
(R) factors and F factors. J. Mol. Biol. 75:235-255. 
99. Shipley, P. L. and R. H. Olsen. 1975. Isolation of a non-
transmissible antibiotic resistance plasmid by transductional 
shortening of R factor RPl. J. Bacterial. 123:20-27. 
100. Smith, H. W. and S. Halls. 1968. The transmissible nature of 
the genetic factor in Escherichia coli that controls hemolysin 
production. J. Gen. Microbial. 47:153-160. 
101. Smith, H. W. and S. Halls. 1968. The transmissible nature of 
the genetic factor in Escherichia coli that controls entero-
toxin production. J • Gen. Microbial. 52:319-326. 
102. So, M., H. W. Boyer, M. Betlach and s. Falkow. 1976. Trans-
position of a plasmid deoxyribonucleic acid sequence that 
mediates ampicillin resistance: independance from host rec 
functions and orientation of insertion. J. Bacterial. ---
ill: 425-434. 
103. Stanier, R. Y., E. A. Adelberg and J. L. Ingraham. 1976. 
General microbiology, 4th edition. The MacMillan Press, 
Ltd., London. 
104. Summers, A. D. and S. Silvers. 1972. Mercury resistance in a 
plasmid bearing strain of Escherichia ££!1. J. Bacterial. 
112:1228-1236. 
105. Tanaka, N., J. H. Cramer and R. H. Rownd. 1976. EcoRl re-
striction endonuclease map of the composite R plasmid NRl. 
J. Bacterial. 127:619-636. 
106. Tanaka, T., M. Tsunoda and S. Mitsuhashi. 1974. Drug resistance 
in Shigella strains isolated in Japan from 1965 to 1973. In 
S. Mitsuhashi and H. Hashimoto (ed.), Microbial drug re-
sistance. University Park Press, Baltimore. 
107. Umezawa, H. 1974. History and development of biochemical 
mechanisms of resistance to aminoglycoside antibiotics and 
their active derivatives, p. 103-119. In s. Mitsuhashi, L. 
Rosival, and V. Krcmery (eds.), Drug inactivation enzymes 
and antibiotic resistance. Springer-Verlag, Berlin. 
109 
108. VanVliet, F., a. Stlva, M. VanMontagu and J. Schnell. 1978. 
Transfer of RP4: Mu plasmids to Agrobacterium tumefaciens, 
Plasmid 1:446-455. 
109. Vapnek, D., M. B. Lipman and W. D. Rupp. 1971. Physical 
properties and mechanism of transfer of R factors in 
Escherichia££!!. J. Bacteriol. 108:508-514. 
110. Watanabe, T. 1963. Infective heredity of multiple drug re-
sistance in bacteria. Bacteriol. Rev. 27:87-115. 
111. Watanabe, T. 1971. The nature of R factors. 
origin of R factors. Ann. N.Y. Acad. Sci. 
Part III. The 
m=l26-14o. 
·112. Watanabe, T. and T. Fukasawa. 1961. Episome mediated transfer 
of drug resistance in Enterobacteriaceae I. Transfer of 
resistance factors by conjugation. J. Bacteriol 81:669-678. 
113. Watanabe, T. and T. Fukasawa. 1961. Episome mediated transfer 
of drug resistance in Enterobacteriaceae II. Elimination of 
R factors with acridine dyes. J. Bacteriol. 81:679-683. 
114. Willets, N. 1972. 
Ann. Rev. Genet. 
The genetics of transmissible plasmids. 
6:257-268. 
115. Womble, D. D., D. P. Taylor and R. M. Rownd. 1977. Method 
for obtaining more accurate covalently closed circular plasmid 
to chromosome ratios from bacterial lysates by dye-bouyant 
density centrifugation. J. Bacteriol. 130:148-153. 
116. Yoshikawa, T. T., S. A. Shibata, A. W. Chow and L. B. Guze. 1978. 
Outbreaks of multiple drug resistant Proteus mirabilis 
originating in a surgical intensive care unit: in vitro 
susceptibility pattern. Antimicrob. Agents Chemother. 13: 
177-179. 
117. Zeuthen, J. and M. C. Pato. 1971. Replication of the Flac :sex 
factor in the cell cycle of Escherichia coli. Mol. Gen. 
Genet. 111:242-255. 
APPROVAL SHEET 
The thesis submitted by Camille Talanda-Fath has been read and approved 
by the following committee: 
Dr. Stephen K. Farrand, Director 
Associate Professor, Microbiology, Loyola 
Dr. Paul O'Keefe 
Assistant Professor of Medicine & Microbiology, Loyola 
Dr. Robert E. Malone 
Assistant Professor, Microbiology, Loyola 
The final copies have been examined by the director of the thesis and 
the signature which appears below verifies the fact that any necessary 
changes have been incorporated and that the thesis is now given final 
approval by the Committee with reference to content and form. 
The thesis is therefore accepted in partial fulfillment of the 
requirements for the degree of Master of Science. 
